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Hyaluronic acid (HA) is one of the primary chemical building blocks of the extracellular 
matrix and thus is an attractive material for biomedical applications. FDA approved HA-
based materials are available as dermal fillers, joint viscosupplements, vitreous 
substitutes, and abdominal adhesion barriers. The engineering of new HA-based materials 
and applications is an active area of research. Here we develop several new types of HA-
based hydrogels with unique and useful properties. To address the challenge of delivering 
hydrophobic drugs from hydrophilic hydrogel matrices we have grafted HA hydrogels 
with β-cyclodextrin to create hydrogels capable of binding poorly water soluble drugs. 
To create HA hydrogels with unique anisotropic swelling behavior we have developed a 
dual-crosslinking technique in which a super-swelling chemically crosslinked hydrogel is 
patterned with low-swelling photocrosslinked domains. When this dual-crosslinked 
hydrogel is swelled it contorts into a new shape because of differential swelling among 
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photopatterned regions. To address the challenge of creating hydrogel scaffolds with 
biomimetic branched porosity we have invented a “crystal templating” technique. This 
technique grows dendritic crystals throughout a biopolymer solution, crosslinks the 
biopolymer around the crystals, and washes the crystals away to yield a hydrogel with a 
dendritic macroporous network. Lastly, we invented a method for patterning a substrate 
with a microarray of hydrogel compartments. A microarray of living cells is obtained 
when cells are seeded on the hydrogel patterned substrate. This method addresses the 
need for an inexpensive, simple method for obtaining living cell microarrays that does 
not require clean room labs and lithographic expertise. Each of these new materials were 
based on hyaluronic acid hydrogels but the methods are generalizable to hydrogels of 
other polymers too. In conclusion, the novel methods in this dissertation are a significant 
contribution to the engineering of HA-based materials. 
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Chapter 1: Introduction to Hydrogels of Hyaluronic Acid 
 
1.1 PROPERTIES OF HYALURONIC ACID 
 Hyaluronic acid (HA) is one of the primary chemical building blocks of the 
extracellular matrix and thus is an attractive material for biomedical applications. HA is 
found naturally in skin, cartilage, intra-articular joint fluid and vitreous humor.[1-3] Its role 
is to maintain tissue hydration, supply compressive strength, and promote cell quiescence 
and tissue homeostasis. Medical grade hyaluronic acid that is obtainable by bacterial 
fermentation is free of immunogenic animal proteins and exhibits excellent 
biocompatibility and non-immunogenicity.[4] HA is degraded in vivo by enzymes (i.e., 
hyaluronidases) that are prevalent in human tissues.[5] The degradation products of 
hyaluronidase digestion are non-toxic oligomeric sugars that can be further digested and 
recycled. Upregulation of HA is observed during development and during embryonic 
wound healing and is correlated with regeneration of scar-free tissue; thus, HA appears to 
play a crucial role in non-scar regeneration, the ultimate goal of tissue engineering.[6,7] 
FDA approved HA-based materials are available in the areas of dermal fillers, joint 
viscosupplementation, vitreous substitutes, and abdominal adhesion barriers.[8-11] The 
invention of new HA-based materials and applications is an active area of research.  
 It is important to recognize that in addition to its attractive qualities HA also 
exhibits several non-ideal properties that should be carefully considered when 
engineering HA-based materials. These are insolubility in organic solvents, susceptibility 
to pH and temperature induced degradation, and high viscosity in aqueous solutions even 
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at dilute concentrations. These properties can make HA difficult to chemically derivatize 
and make HA materials difficult to process. Therefore, the creation of novel HA-based 
materials is dependent on developing synthesis and fabrication techniques that are 
compatible with HA’s unique combination of properties.  
 The form of HA used in Schmidt lab and throughout this dissertation is a 
photocrosslinkable derivative (GMHA) synthesized by the reaction of glycidyl 
methacrylate with hyaluronic acid. GMHA is hyaluronic acid with pendant methacrylate 
functionalities. Photocrosslinked hydrogels can be prepared by UV exposure of GMHA 
solutions containing photoinitiator. UV exposure initiates radical polymerization of the 
pendant methacrylate functionalities and the resulting hydrogel consists of long 
hyaluronic acid chains crosslinked by short polymethacrylate chains. Previously, Schmidt 
lab has developed and characterized the basic properties of GMHA hydrogels,[12] 
functionalized GMHA hydrogels with cell-adhesive peptides,[13] and explored the release 
of protein from GMHA hydrogels.[14] The new research detailed in this dissertation uses 
GMHA hydrogels as the starting material in the creation of novel HA-based materials for 
drug delivery, and tissue engineering, and microarray applications.  
 
1.2 DRUG-BINDING HYALURONIC ACID HYDROGELS FUNCTIONALIZED 
WITH β-CYCLODEXTRIN 
 The function of a tissue engineering scaffold is to provide a temporary structural 
framework that can direct cells to regenerate scar-free healthy tissue. Polymer scaffolds 
alone are not sufficient for tissue regeneration because they provide only insoluble 
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structural components without soluble chemical signals. The next generation of polymer 
scaffolds needs to integrate the delivery of soluble chemical signals to promote tissue 
regeneration. The aqueous micro-environment and the large mesh size of HA hydrogels 
is well-suited for the sustained release of high molecular weight water-soluble drugs. 
Indeed, the release of growth factors from HA matrices has been demonstrated to have 
beneficial effects on cell viability and scaffold vascularization.[15,16] There are also 
important low molecular weight (i.e., MW < 1000 Da) poorly water soluble organic 
molecules that enable aspects of cell signaling. It is challenging to release these types of 
hydrophobic molecules from HA hydrogels because drug loading is severely limited in 
the aqueous micro-environment. The goal for this particular project was to design and 
synthesize an HA hydrogel that can release low molecular weight hydrophobic drug. 
 The strategy was to functionalize GMHA hydrogels with β-cyclodextrin (βCD) to 
endow the hydrogels with a drug-binding capability. βCD is a cyclic oligomer of seven 
glucose units that is obtained from the bacterial degradation of starch. Each βCD 
molecule is a cup-shaped nano-container with a hydrophobic cavity ~6 Å in diameter and 
~260 Å3 in volume.[17] In aqueous solution the βCD molecule can host a guest 
hydrophobic molecule within this cavity. The exterior of the βCD molecule is rendered 
hydrophilic by an array of hydroxyls that surround the hydrophobic cavity and guest. 
Formulations of βCD-drug complexes have been used by pharmaceutical scientists for 
many years to increase the solubility of poorly water soluble drugs.[18] The interactions 
between βCD and drug are non-covalent; thus, complexes in solution are at equilibrium 
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with free βCD and free drug. Conditions favorable to complexation are low drug 
solubility and high complementarity between the sizes of the drug and the cavity. 
 The objectives of this project, detailed in Chapter 3, were to (i) synthesize a 
methacryloyl-βCD monomer; (ii) synthesize GMHA hydrogels functionalized with the 
methacryloyl-βCD monomer; (iii) demonstrate enhanced drug absorption and drug 
release by GMHA-βCD hydrogels relative to ordinary non-functionalized GMHA 
hydrogels; and (iv) prove unambiguously the existence of drug-hydrogel complexes 
within the GMHA-βCD hydrogel system. 
 
1.3 DUAL-CROSSLINKED HYDROGELS EXHIBITING ANISOTROPIC 
SWELLING 
 Swelling is a characteristic property of hydrogels caused by the diffusion of 
hydrogel polymer chains in solution.  A swelling hydrogel increases in both weight and 
volume due to uptake of water. Total dissolution of the hydrogel is prevented by the 
presence of chemical crosslinks. The inverse relationship between crosslink density and 
swelling is the basis for this project.  
 The goal of this project was to synthesize a hydrogel that exhibits anisotropic 
swelling. The strategy consisted of synthesizing chemically crosslinked hydrogels and, 
before swelling them, patterning with photocrosslinks. The addition of photocrosslinks 
within the hydrogel increases the local crosslink density and decreases local equilibrium 
swelling. When the hydrogel is placed in solution the chemically crosslinked domains 
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will swell to a high degree and the dual-crosslinked domains (i.e., domains with both 
chemical crosslinks and photocrosslinks) will swell to a low degree. Anisotropic swelling 
will permit the hydrogel to contort and evolve a shape different from that of the 
unswollen hydrogel. Such shape changing hydrogels with patterned anisotropic swelling 
have not been reported. A biodegradable HA-based hydrogel with this type of swelling 
behavior would yield a new, unexplored type of shape changing tissue engineering 
scaffold. 
 The objectives of this project, detailed in Chapter 4, were (i) characterize the 
swelling of HA hydrogels chemically crosslinked by butanediol diglycidyl ether; (ii) 
characterize the swelling of photocrosslinked GMHA hydrogels; and (iii) combine 
chemical and photocrosslinking within a single hydrogel system to create hydrogels with 
anisotropic swelling. 
 
1.4 HYALURONIC ACID HYDROGELS WITH DENDRITIC POROSITY 
OBTAINED BY CRYSTAL TEMPLATING 
 There are two kinds of porosity within a hydrogel. Micro-porosity consists of the 
pores among individual polymer chains. This porosity is a result of the solvation of HA 
by water which induces HA chains to swell. The length scale of microporosity is on the 
order of 10 nm to 100 nm which is sufficient for the diffusion of water, oxygen, salts, and 
low molecular weight metabolites. Macro-porosity is on the length scale of 1 µm to 100 
µm. Tissue engineered scaffolds require macro-porosity to permit rapid protein diffusion, 
cellular migration, and ingress of microvessels from surrounding tissue. 
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 Several methods have been developed to create polymeric scaffolds with macro-
porous networks. Rapid prototyping techniques (e.g., 3D printing and stereolithography) 
use software to plot the porous networks which are precisely sculpted in three dimensions 
by a method suitable to the polymer of interest.[19-21]  Simpler techniques use a particulate 
leeching strategy such as leeching of salt crystals or microspheres from crosslinked 
polymer scaffolds.[22-24] Another method is the freezing of a polymer solution followed 
by sublimation of solvent (e.g., lyophilization of PLGA-dioxane solutions).[25-27]  
 A limitation of these methods is that they are incompatible with HA hydrogels 
because they require extreme temperature or pH, polymer solubility in organic solvent, or 
concentrated low viscosity solutions. A further limitation is that the above methods are 
unable to create the dendritic porous architecture that is exhibited by microvasculature, 
glandular epithelial ducts, and networks of nerve endings. 
 This project concerns the invention of a “crystal templating” technique for 
patterning biopolymer hydrogels with dendritic macro-porous networks. Large dendritic 
crystals (i.e., crystal templates) were grown within aqueous HA solutions. The 
biopolymer was then crosslinked around the template and the template was washed out 
with water. The advantages of this technique are that it creates unique branched 
networks, requires no extreme temperature or pH, can be scaled and performed in 
parallel, and has no requirement for expensive machines and instruments such as those 
that are necessary for rapid prototyping.  
 The objectives of this project, detailed in Chapter 5, were (i) develop a crystal-
templating technique to pattern HA hydrogels; (ii) characterize the morphology of the 
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patterned hydrogel; and (iii) identify the key parameters that determine the resulting 
macroporous network structure.  
 
1.5 LIVING CELL MICROARRAYS OBTAINED BY PATTERNED HYDROGEL 
MESHES 
 Highly developed technologies have been invented in recent years for the 
fabrication of DNA microarrays.[28] The microarrays consist of biological molecules 
covalently tethered to a substrate in a defined grid pattern. The microarray facilitates high 
throughput data acquisition and image analysis and has permitted a number of new 
diagnostic assays to be developed. In contrast to the advances of biomolecule microarrays 
the development of living cell microarrays has not progressed as far. The  fundamental 
hurdle of  creating  cell microarrays  is obtaining  a grid of  cell‐adhesive  compartments. 
Current methods  use  clean  room  equipment  and  lithographic  techniques  to  fabricate 
grid  patterns,  but  access  to  this  equipment  has  been  identified  as  a  significant 
impediment to the spread of living cell microarrays to many research groups.[29]  
  This project describes the invention of an extremely simple method for patterning 
living cell microarrays. This  invention  fulfills  the  need  for  a  simple  cell  patterning 
technique that can be easily disseminated to other research labs without transference of 
custom made apparatuses, clean room expertise, and specialized technical and chemical 
synthetic  skills.  The  key  insight  to  our  invention  is  that  nylon mesh  in  the  desired 
appropriate  grid  pattern  is  abundantly  available,  off‐the‐shelf,  and  inexpensive. We 
8 
developed  a method  for  transferring  the grid pattern  from nylon mesh  to a hydrogel 
mesh adhered  to a  cell  culture  substrate. The hydrogel mesh  is non‐cell adhesive and 
delineates  individual microarray compartments. Biological cells  that are seeded on  the 
patterned  substrate  adhere  to  the  individual  compartments  but  not  the  hydrogel 
partitions.  This  patterning method  can  array  both  cell  clusters  and  single‐cells  thus 
paving the way for truly single‐cell assays and diagnostics. 
 Cell microarrays are applicable as cell-based sensors of environmental toxins and 
pathogens, cell-based medical diagnostics, and in vitro drug screening assays.[30] 
Furthermore, cell microarrays and biomolecule microarrays can be expected to be highly 
synergistic technologies. For example, cell microarrays overlaid on DNA microarrays can 
be used to create transfection arrays, loss of function arrays, and other assays of cell 
response to the underlying biomolecules.[31, 32] 
  The objectives of  this project, detailed  in Chapter 6, were  (i) develop a method 
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Chapter 2: Photocured Hydrogel Films of Hyaluronic Acid 
 
Abstract 
This chapter discusses two protocols that are used throughout the remaining chapters. 
These protocols and experimental data comprise the early preliminary work of this 
dissertation. The first protocol is the synthesis of photocrosslinkable glycidyl 
methacrylate modified hyaluronic acid (GMHA). This derivative was synthesized by the 
reaction of glycidyl methacrylate with HA in a solvent mixture of water and acetone. The 
novelty of this protocol is that it used an organic water mixture to increase the degree of 
methacryloyl substitution. The second protocol is the synthesis of photocured GMHA 
hydrogel films. The literature describes many methods for creating films of hyaluronic 
acid. These methods typically consist of mixing HA with a chemical crosslinker in 
solution, adjusting the pH, casting the solution, and evaporating the solvent. This method 
has the advantage of simplicity but lacks reproducibility of film properties. To address 
the lack of reproducibility we developed a novel method of synthesizing photocured 
GMHA films. These films were prepared by mixing GMHA with a photoinitiator and 
casting the solution. After solvent evaporation the film was crosslinked by one minute 
exposure to UV light. This photocrosslinking method produced hydrogel films with a 
greater degree of control over the crosslinking reaction than is possible with chemical 
crosslinking methods. The photocured GMHA films were transparent, low swelling, and 
resistant to cell adhesion.  
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2.1 Introduction 
 In this dissertation a hydrogel film refers to a thin, planar, free-standing, water-
swelling material. Hydrogel films resist protein adsorption and cell adhesion because they 
are surrounded by a layer of tightly bound water molecules. These properties permit 
hydrogels to evade cellular detection and exhibit high degrees of non-immunogenicity 
and biocompatibility. The porous, hydrated properties of hydrogels permit the diffusion 
of oxygen, ions, metabolites, nutrients, and even proteins if hydrogel pores are large 
enough.[1] Hydrogel films may be applied as tissue engineered scaffolds and drug 
delivery reservoirs.[2,3] Some hydrogel films are used as abdominal adhesion barriers to 
prevent the formation of scar tissue between intra-abdominal surfaces that are wounded 
during surgery.[4] Genzyme’s Seprafilm™ is an adhesion barrier partially composed of 
hyaluronic acid.[5] Hydrogel films of hyaluronic acid (HA) have the additional properties 
of biodegradability by hyaluronidases that are found in human tissues in vivo.[6] 
 The literature describes many methods for producing HA films. Common 
chemical crosslinkers are diglycidyl ethers and divinyl sulfone.[7] Crosslinking typically 
consists of mixing HA with the crosslinker, adjusting the pH, casting the solution, and 
evaporating the solvent. This evaporation step can require several days or longer 
depending on the desired thickness of the film. After evaporation the films are neutralized 
with dilute acid or base and washed with organic solvents to remove excess crosslinker. 
The advantage of this technique is its simplicity. The primary disadvantage is extremely 
poor reproducibility of hydrogel properties due to several factors. First, the concentration, 
viscosity, and pH of the solution changes dramatically during solvent evaporation; 
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therefore, the crosslinking reaction is uncontrolled. Second, HA is sensitive to acid and 
base conditions; therefore, there is simultaneous uncontrolled degradation of the HA 
backbone during solvent evaporation. Third, the ambient humidity and temperature can 
radically affect the rate of evaporation and the final water content of the cast films, thus  
further impairing control of the crosslinking reaction. Lastly, neutralization of the pH is 
difficult because it is not possible to accurately predict the pH of the evaporated films nor 
is it possible to accurately measure the pH within the hydrogel. An additional 
disadvantage is the inability to encapsulate proteins and drugs within the hydrogels due to 
cross-reactivity with the crosslinker and pH-induced degradation. 
 We have used the technique of photoinitiated crosslinking to circumvent the 
disadvantages of chemical crosslinking. We prepared an aqueous solution of a 
methacryloyl-derivative of hyaluronic acid (GMHA) and photoinitiator (Irgacure 2959). 
The solution was cast into a dish and evaporated at ambient conditions. After evaporation 
the hydrogel films were exposed for one minute to 365 nm UV light to initiate 
polymerization of methacryloyl functionalities. The reproducibility of this method was 
much improved compared to chemical crosslinking in several respects. First, the pH did 
not need to be altered. Second, there was no chemical reaction during the lengthy 
evaporation step which was the primary source of heterogeneity in the chemical 
crosslinking reaction. Third, there was no degradation of hyaluronic acid due to acidic 
and basic conditions. Fourth, no pH neutralization step was required. Fifth, organic 
solvents were not needed to rinse out oily chemical crosslinkers; water was sufficient for 
removing the aqueous-soluble Irgacure 2959. Sixth, the photocrosslinking reaction was 
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easily controlled by modulating the duration of UV exposure. Lastly, the method is more 
compatible with encapsulated drugs and proteins.  
 A limitation of the photocuring method is that a chemical synthetic step is 
required to render HA photocrosslinkable; whereas, chemical crosslinking can be 
performed with unmodified HA directly off-the-shelf. An important parameter that 
impacts the success of photocuring is the hygroscopicity of the evaporated hyaluronic 
acid films. The air-dried films possess a water content that is in equilibrium with the 
ambient humidity. This water content has a decisive effect on the diffusion of 
photoinitiator and methacryloyl groups within the air-dried films. We found that 
dessicated films exposed to UV did not crosslink and rapidly dissolved in water. 
Therefore, to ensure reproducibility of the hydrogel properties it is important to 
equilibrate the ambiently dried films at a well-defined humidity until  immediately prior 
to UV exposure. 
 Another important consideration is the number of methacryloyl groups grafted to 
the HA backbone. HA can be reacted with either methacrylic anhydride or with glycidyl 
methacrylate (GMHA) to produce a photocrosslinkable derivative.[8,9] The grafting 
reaction must be performed in aqueous solution because HA is insoluble in organic 
solvents. The exclusion of organic solvents is problematic because the methacryloyl 
reactants are poorly water soluble and high concentrations are needed for the grafting 
reaction. Therefore, we investigated the reaction of glycidyl methacrylate with HA in 
mixtures of water and acetone that we predicted would be more effective at solubilizing 
both HA and glycidyl methacrylate than water alone. To perform this reaction a base, 
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triethylamine, was used to activate the primary hydroxyls of HA. The activated hydroxyls 
attack the epoxide ring of the glycidyl methacrylate. The resulting GMHA derivative 
consists of hyaluronic acid with methacryloyl functionalities linked through epoxy 
spacers to the primary hydroxyls of HA. The degree of substitution (DS) is the 
percentage of HA disaccharides that are substituted with a methacryoyl functionality. The 
goal of our first experiments was to maximize the DS of the GMHA derivative by 
changing the solvent composition. The goal of the remaining experiments in this chapter 
was to use the GMHA thus obtained to create photocured hydrogel films. 
 
2.2 Results and Discussion 
 2.2.1 Water/Acetone mixtures for HA modification. The chemical structures of 
hyaluronic acid and glycidyl methacrylate are given in Figure 2.1. The HA molecule is 
highly water soluble because of the high density of hydroxyls and carboxyls along the 
HA backbone. In organic solvents HA undergoes strong intramolecular hydrogen 
bonding and precipitates from solution. Water is a polar protic solvent whereas acetone is 
a polar aprotic solvent. We predicted that water/acetone mixtures would facilitate the 
reaction of glycidyl methacrylate with hyaluronic acid by solubilizing the reactants more 
effectively than water alone. Furthermore, polar aprotic solvents favor SN2 reactions such 
as the base catalyzed ring-opening of epoxides. Increasing the proportion of acetone in 
the solvent mixture decreases the mixture’s protic character and will increase the 
solubility of glycidyl methacrylate; however, if the protic character of the mixture is 
decreased too much the HA will precipitate. Therefore, our first step was to test the 
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solubility of HA in mixtures of water and acetone. We found that HA was soluble up to 
1% w/v in solvent mixtures of up to 50% acetone but not soluble in mixtures with greater 
proportions of acetone.  
 The reaction of glycidyl methacrylate with HA was performed in either pure 
water (GMHA00), 70/30 water/acetone (GMHA30) or 50/50 water/acetone (GMHA50). 
The DS was determined from 1H NMR spectra by taking the ratio of glycidyl 
methacrylate methyl protons to HA methyl protons (Figure 2.2). GMHA00 had a DS of 
11 ± 2.8% (average of two synthesis batches); GMHA30 had a DS of 24 ± 1.2% (average 
of three synthesis batches); and GMHA50 had a DS of 33 ± 1.0% (average of three 
synthesis batches). Based on NMR data the addition of acetone facilitated the reaction of 
glycidyl methacrylate with HA. 
 Hydrogels synthesized from GMHA with increasing DS should have a greater 
density of poly(methacrylate) crosslinks and reduced swelling. We found that GMHA00 
hydrogels swelled to 55 ± 3.0 g PBS/g polymer; GMHA30 hydrogels swelled to 36 ± 1.9 
g PBS/g polymer; and GMHA50 hydrogels swelled to 31 ± 1.5 g PBS/g polymer (Figure 
2.3). Thus, these results supported the hypothesis that increasing acetone would facilitate 
methacryloyl substitution and decrease swelling. 
 We reasoned that GMHA hydrogels with a greater DS would exhibit slower 
degradation rates due to increased crosslink density. Hydrogels were degraded in 
solutions containing hyaluronidase, an enzyme that degrades HA in vivo. Degradation 
was followed by measuring the weights of the hydrogels. The time to 50% weight loss of 
GMHA00 hydrogels was 0.66 ± 0.06 hours; for GMHA30 hydrogels the time was 4.5 ± 
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0.46 hours; and for GMHA50 hydrogels the time was 13 ± 1.6 hours (Figure 2.4). Thus, 
these results supported the hypothesis that increasing acetone composition in the reaction 
mixture facilitates methacryloyl substitution. In conclusion, we demonstrated that a 
mixture of 50/50 water/acetone maximizes the number of methacryloyl groups grafted to 
HA. Complementary data obtained by NMR, swelling, and degradation consistently 
supported this conclusion. Similar results in which a GMHA derivative was synthesized 
with a 90% DS in a 50/50 co-solvent of water/DMF are support our hypothesis that polar 
aprotic solvent mixtures can facilitate the reaction of HA with hydrophobic reagents.[10] 
 2.2.2 Photocuring of GMHA hydrogel films. The GMHA derivative synthesized 
in 50:50 water/acetone was used to create both solvent cast photocured hydrogel films as 
well as hydrogels photocrosslinked in solution. Photographs of a GMHA hydrogel film 
(left) and solution photocrosslinked hydrogels (right) are depicted in Figure 2.5. The 
solution photocrosslinked hydrogels are the basis of the cyclodextrin-HA hydrogels in 
Chapter 3. The hydrogel films are used throughout Chapter 5 and are the basis of the 
hydrogel meshes in Chapter 6. These hydrogel films were optically transparent, flexible, 
and mechanically robust to handling.  
 The synthesis conditions of photocured films were optimized with respect to 
duration of UV exposure and concentration of photoinitiator. First, hydrogel films were 
prepared from solutions of 1% w/v GMHA50 in water with Irgacure 2959 at a 
concentration of 5% w/w with respect to GMHA. After solvent casting and evaporation, 
the hydrogel films were exposed to various durations of UV exposure ranging from 15 
seconds to 5 minutes. The goal was to find the minimum amount of UV exposure 
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required to produce mechanically stable photocured hydrogel films. Films that were 
exposed to 15 seconds of UV dissolved rapidly in water indicating that insufficient 
crosslinks had formed. Films that were crosslinked with 30 seconds of UV exposure did 
not dissolve. Quantitative measurements of swelling based on weight (i.e., swelling ratio) 
and diameter (i.e., % linear swelling) indicated that swelling was not strongly dependent 
on UV exposure in the range of 30 seconds to 5 minutes (Figure 2.6a); however, 
qualitative assessment of mechanical stability indicated that films exposed to only 30 
seconds of UV were more fragile than films exposed to UV for longer durations. UV 
exposures beyond 1 minute did not appear to have an effect on the stability of the 
hydrogel films. Based on these results, we used 1 minute of UV exposure as the default 
exposure time for photocured hydrogel film synthesis. 
 Next, hydrogel films were prepared with various concentrations of photoinitiator 
ranging from 1% to 10% w/w. All films were exposed to 1 minute of UV. The trends in 
swelling ratio and % linear swelling were similar. Films with 2.5% and 1.0% w/w 
photoinitiator absorbed more solution and swelled to greater diameters than films with 
5% and greater photoinitiator (Figure 2.6b). Based on these results, the optimum 
photoinitiator concentration was determined to be 5% w/w because it minimized 
swelling. 
 HA has a high density of hydroxyls and carboxyls on the backbone. These groups 
tightly bind water molecules and permit hydrogels produced from HA to resist protein 
adsorption and cell adhesion. This is a useful property for applications such as adhesion 
barriers, drug delivery matrices, and protective coatings for which non-biofouling 
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surfaces are desired. To rigorously challenge the ability of the photocured films to resist 
cell adhesion we selected experimental conditions that strongly favor cell adhesion.  
Normal human dermal fibroblasts (nHDF) are a cell type that is particularly durable, 
secretes many extracellular matrix molecules that support adhesion, and robustly adheres 
to a variety of surfaces. Furthermore, we used cell culture media supplemented with 10% 
fetal bovine serum; thus, the media had a high concentration of proteins that can adsorb 
to the hydrogel surface and support cell adhesion. Hydrogel films were incubated in 
media with 10% serum for 24 hours prior to cell seeding. Cell adhesion was assessed 24 
hours after cell seeding by staining cells with calcein, a fluorescent dye that labels live 
cells. Fibroblasts failed to adhere to photocured GMHA films proving that these films can 
resist cell adhesion even under conditions that strongly favor adhesion (Figure 2.7). 
Positive control substrates of tissue culture polystyrene supported the growth of 
fibroblasts. 
 Surprisingly, previous work on photocured HA hydrogel films appears to be 
limited to a series of US patents issued to Seikagaku Corporation (US Patent #5,462,976, 
#5,763,504, #6,602,859). Their chemical synthetic strategy was to functionalize HA with 
cinnamic acid, uracil, and thymine chemical groups. Irradiation by UV light induces 
these functionalities to undergo dimerization through cyclobutane linkages. A recent 
patent application by Seikagaku Corporation (US Patent Application 20060057098) 
claims photocured HA films obtained by acryloyl and methacryloyl polymerization in 
addition to the cyclobutane dimerization chemistries. This patent application also 
describes performing the methacrylate functionalization of HA in aqueous solvent 
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mixtures of up to 50% organic solvent. This similar line of research indicates the utility 
and potential commercial use of these protocols for engineering HA-based materials. 
 In conclusion, this chapter describes two protocols: one protocol for synthesizing 
GMHA and another protocol for creating photocured GMHA films. In subsequent 
chapters, GMHA always indicates that the photocrosslinkable HA derivative was 
prepared in 50/50 water/acetone and has an average DS of 33%. All GMHA hydrogel 
films in later chapters (i.e., Chapter 5 and Chapter 6) were cast from 1% GMHA 
solutions with 5% w/w Irgacure 2959 and 1 minute of UV exposure. 
 
2.3 Materials and Methods 
 2.3.1 Materials. High molecular weight sodium hyaluronate from Streptococcus 
equi of molecular weight 1.6x106 Da and bovine testicular hyaluronidase (1000 U/mg) 
were obtained from Sigma-Aldrich (St. Louis, MO). Irgacure 2959 was obtained from 
Ciba Specialty Chemicals (Basel, Switzerland). All other chemicals and reagents were 
obtained from Sigma-Aldrich. Circular silicone rubber molds (Grace Bio-Labs, Bend, 
OR) of 9 mm diameter and 2 mm thickness were used for making hydrogels. A longwave 
UV lamp filtered around 365 nm and with an intensity of 22 mW/cm2 was used to initiate 
photopolymerization (Blak-Ray B-100A, UVP, Upland, CA).  
 2.3.2 Methacryloyl modification of hyaluronic acid (GMHA). Hyaluronic acid 
was conjugated with photopolymerizable methacryloyl groups by reaction with glycidyl 
methacrylate. The reaction was performed in either pure water (GMHA00), 70/30 
water/acetone (GMHA30) or 50/50 water/acetone (GMHA50). A 1% w/v solution of HA 
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was prepared in the appropriate solvent and stirred 24 hours. Twenty molar equivalents of 
triethylamine as base catalyst and twenty molar equivalents of glycidyl methacrylate 
were added to the solution and stirred for 24 hours at room temperature. The glycidyl 
methacrylate-modified hyaluronic acid (GMHA) was precipitated into a 20-fold 
volumetric excess of acetone, dissolved in water for 24 hours, precipitated a second time, 
redissolved in water for another 24 hours, and lyophilized.  
 2.3.3 NMR. 1H NMR samples were dissolved in deuterium oxide at 10 mg/mL 
and the spectra recorded on a Varian Unity +300 spectrometer. The degree of substitution 
(DS) was calculated by integration of HA methyl protons (1.90 ppm, 3 H atoms) and 
methacrylate methyl protons (1.85 ppm, 3 H atoms). 
 2.3.4 Preparation of photocrosslinked GMHA hydrogels. Gelation solutions of 
20 mg/mL GMHA were prepared in phosphate buffered saline (PBS, 10 mM, pH 7.4) 
containing 1% w/v Irgacure 2959 and 0.3% N-vinyl pyrrolidone. Hydrogels were each 
prepared from 100 µL of gelation solution and 5 minutes of UV exposure. The hydrogels 
were then swelled to equilibrium in PBS and rinsed with several exchanges of PBS to 
remove photoinitiator. 
 2.3.5 Hydrogel swelling ratio measurements. A small portion of each swollen 
gel, 10-15 mg, was placed in a thermogravimetric analyzer (Perkin Elmer TGA 7) and 
heated at 100°C until all water was evaporated and a constant dry weight obtained. The 
mass of residual PBS salts contributing to the dry weight was determined from the mass 
of evaporated water and was subtracted to obtain the dry weight of the polymer alone. 
The swelling ratio was calculated according to Equation 3, where SR [g PBS / g polymer] 
is the swelling ratio, WS [g] is the swollen weight of the hydrogel, and WD [g] is the dry 
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 2.3.6 Enzymatic degradation of GMHA hydrogels. A stock solution of 
hyaluronidase (500 U/mL) was prepared in citrate buffer. Hydrogels were swollen to 
equilibrium in citrate buffer. The swollen weight of the hydrogels was measured on an 
analytical balance. The hydrogels were then transferred to hyaluronidase solution and 
incubated at 37°C. The hydrogels were removed at various timepoints, carefully blotted, 
and reweighed. The hydrogels were then placed in fresh hyaluronidase solution. 
Hydrogels were degraded until complete dissolution. The percent degradation was 
calculated by Equation 2. Eight hydrogels were analyzed per condition but some 
hydrogels broke into small pieces at later time points due to degradation and were 
discarded. 
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 2.3.7 Preparation of photocured GMHA hydrogel films. Aqueous solutions 
were prepared containing 1% w/v GMHA and 0.05% w/v Irgacure 2959. All steps were 
performed sterilely to prevent bacterial growth in the hyaluronic acid solutions. The 
solution was filter sterilized (0.22 µm PVDF, Millipore) and dispensed into sterile, non-
tissue culture treated 12-well plates. Each well was 2.2 cm in diameter and a volume of 
2.6 mL of sterile solution was dispensed per well. The solvent was evaporated in a sterile 
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horizontal flow hood in the dark for four days at ambient temperature and humidity. After 
evaporation, the films were humidified for four days in humid chambers equilibrated with 
saturated salt solutions. The films were photocrosslinked by exposure to UV light for 30 
seconds to 5 minutes. 
 2.3.8 Photocured film swelling studies. After photocrosslinking, hydrogel films 
were dessicated and weighed on an analytical balance. The films were then swelled in 
PBS at 37°C for 24 hours. The swollen films were carefully blotted to remove excess 
liquid and reweighed. The swelling ratio was calculated by Equation 1 given above. The 
diameter of the films was measured with electronic calipers. The % linear swelling was 
calculated by Equation 3 in which the swollen and dry diameters are DS and DD 
respectively. 
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 2.3.9 Cell adhesion study. Normal human dermal fibroblasts were obtained from 
Cambrex and cultured in DMEM with 10% fetal bovine serum (FBS). The fibroblasts 
were seeded onto either tissue culture polystyrene (positive control) or onto photocured 
GMHA hydrogels films. Hydrogel films were incubated in DMEM with 10% FBS for 24 
hours prior to cell seeding. After 24 hours the cells were stained with 4 mM calcein AM 
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Figure 2.1 Chemical structures of hyaluronic acid and glycidyl methacrylate. 












Figure 2.2 Full spectrum 1H NMR spectra of GMHA50 (a) and expansion of methyl 
proton signals (b). The DS was determined by integrating the signals at 1.855 ppm and 
1.928 ppm and calculating the ratio. The DS was 0.32 methacryloyl groups per 











Figure 2.3 Swelling ratios of GMHA hydrogels in PBS.  GMHA was synthesized in 
solvents containing different compositions of water and acetone. GMHA synthesized in 
solvents with greater percentages of acetone produced hydrogels with greater crosslink 
density and less swelling; therefore, increasing amounts of acetone facilitated the grafting 































Figure 2.4 Enzymatic degradation of GMHA hydrogels by hyaluronidase at 37°C. 
GMHA was synthesized in solvents containing different compositions of water and 
acetone. GMHA synthesized in solvents with greater percentages of acetone produced 
hydrogels with greater crosslink density and slower rates of degradation; therefore, 
increasing amounts of acetone facilitated the grafting of glycidyl methacrylate onto 
hyaluronic acid.  GMHA00 = diamonds. GMHA30 = squares. GMHA50 = triangles. 






















Figure 2.5 Photograph of photocured GMHA hydrogel films (left) and solution 
photocrosslinked GMHA hydrogels (right). GMHA hydrogel films are flexible, thin, and 
have a very high polymer concentration. Film dimensions are 2.2 cm in diameter and 
~500 µm in thickness. Solution photocrosslinked GMHA hydrogels are rigid, thick, and 




































Figure 2.6 Swelling of photocured GMHA films as a function of UV exposure (a) and 
concentration of photoinitiator (b). Swelling ratio (∆) is the amount of solution absorbed 
by the hydrogels. % linear swelling (□) is the change in diameter of the swollen 
hydrogels. Photoinitiator was held constant at 5% w/w in (a) and UV exposure was held 
constant at 1 minute in (b). Swelling was not strongly dependent on UV exposure for 
durations longer than 30 seconds. Swelling was minimized by photoinitiators 




























Figure 2.7  GMHA photocured films resist cellular adhesion. Human dermal fibroblasts 
were unable to adhere to GMHA films (left) but exhibited high adhesion to tissue culture 








* Portions of the figures and text in this chapter are taken from the following journal article: Zawko, S.A., 
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J. Biomed. Mater. Res. A, In Press. 
Chapter 3: Drug-binding Hydrogels of Hyaluronic Acid 
    Functionalized with β-Cyclodextrin*
 
Abstract 
Hyaluronic acid (HA) hydrogels are attractive materials for biomedical applications 
because they are porous, water-swelling, biocompatible, biodegradable, and resistant to 
non-specific cell adhesion. A limitation of HA hydrogels is that incorporation of 
bioactive drugs is restricted by low solubility of drug within the hydrogel environment. 
Our goal was to synthesize HA hydrogels that bind drug through hydrophobic 
interactions as a method for increasing drug loading. We functionalized photocrosslinked 
HA hydrogels with a methacryloyl derivative of β-cyclodextrin (βCD). βCD is a 
molecular “basket” with a hydrophilic exterior and a hydrophobic cavity. Inclusion 
complexes are formed when βCD hosts all or part of a hydrophobic drug within the 
cavity.  HA hydrogels functionalized with methacryloyl-βCD monomer gained the 
property of inclusion complexation which greatly enhanced the uptake of a model 
hydrophobic drug, hydrocortisone. Pre-incubation of the hydrogels with adamantane 
carboxylic acid (ACA) inhibited hydrocortisone uptake by competition for βCD cavities. 
In addition, HA hydrogels functionalized with αCD monomer were not efficient at 
hydrocortisone uptake because the αCD cavity is too small for efficient complexation. 
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These experiments confirmed that the βCD monomer enhances drug loading by the 
mechanism of inclusion complexation. Drug binding HA-βCD hydrogels may be further 
engineered to create HA-based biomaterials with a built in drug delivery capability. 
 
3.1 Introduction 
 Hyaluronic acid (HA) is a linear biopolymer found ubiquitously in the tissues of 
the body and particularly in synovial fluid, skin and vitreous.[1] Aqueous solutions of HA 
can be crosslinked to produce insoluble hydrogels that exhibit high water content, high 
porosity, degradability by hyaluronidases, and resistance to cell adhesion. Commercial 
HA-based products include dermal fillers, adhesion barriers, and intra-articular 
viscosupplements.[2-4] HA tissue engineering scaffolds have been designed for cartilage, 
skin, adipose and vocal cord.[5-11] Hydrogel matrices are uniquely suited for biomedical 
applications because they resemble natural tissues with respect to mechanical properties, 
porosity, and water content.[12] It is desirable to find methods for building drug delivery 
capability into hydrogels to permit them to locally deliver bioactive agents while also 
functioning as adhesion barriers, wound dressings, tissue engineering scaffolds, and other 
devices.[13] However, incompatibility between hydrophobic drugs with the aqueous 
hydrogel environment may induce drug crystallization which can result in poor hydrogel 
properties and irregular release kinetics. In addition, hydrophobic drugs may migrate to 
the surface of the hydrogel upon drying and result in burst release.[14] Hydrophobic 
peptides and proteins within hydrogels may aggregate causing poor bioavailability.  
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 Steroidal drugs in particular are widely applicable to biomedical applications of 
HA hydrogels such as adhesion barriers and wound dressings. Covalent conjugation has 
been used to solubilize steroids by tethering to HA through hydrolytically labile bonds, 
but this requires chemical modification of the drug and makes the drug’s release 
dependent on environmental pH.[15-17] Our goal is to synthesize a complexing hydrogel 
based on hyaluronic acid that will bind drug non-covalently and improve drug-hydrogel 
interactions and drug loading. We have synthesized a photocrosslinkable monomer based 
on cyclodextrin which can form inclusion complexes with hydrophobic drugs. When this 
monomer is copolymerized with a photocrosslinkable HA derivative the result is an HA 
hydrogel with drug binding property. 
 There are several types of commercially available cyclodextrins (CD) and 
derivatives but the types used in this paper are αCD and βCD. The αCD is a cyclic 
oligomer of six glucopyranose units and βCD is composed of seven glucopyranose units. 
CD resembles a molecular “basket” with a hydrophilic exterior and a hydrophobic cavity. 
The cavity is accessible to small poorly water soluble drugs in aqueous solution. An 
inclusion complex is formed when CD wholly or partially includes a drug within the 
hydrophobic cavity (Figure 3.1). Inclusion complexes are typically more soluble than the 
uncomplexed drug; therefore, the formulation of inclusion complexes is a method of drug 
solubilization.[18] CDs also interact with peptides and proteins such as cyclosporin, 
insulin and human growth hormone through complexation of hydrophobic amino 
acids.[19] Such interactions inhibit aggregation, degradation and denaturation. 
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 The equilibrium concentrations of drug, CD, and complex in aqueous solution are 
given by an association constant, Ka, which is dependent on the solubility, size, and shape 
of the drug and CD cavity. The diameters of αCD and βCD are ~5 Å and ~6 Å, 
respectively; consequently, some drugs that complex with βCD are too big to complex 
with αCD.[19,20] The range of cyclodextrin-ligand association constants spans several 
orders of magnitude. At the high end is the interaction of βCD with adamantane 
derivatives which are roughly spherical hydrocarbons with poor water solubility and a 
size complementary to the βCD cavity. The association constant of adamantane 
carboxylic acid with βCD is on the order of 104 M-1.[21]  
 The corticosteroid hydrocortisone was chosen as our model drug because its 
interactions with both βCD and αCD have been well characterized. Hydrocortisone is 
classified by USP as “very slightly soluble” in water (i.e., one part soluble in 1,000 - 
10,000 parts solvent).[22] Hydrocortisone forms strong complexes with βCD with an 
association constant on the order of 103 M-1.[20,23,24] With αCD, however, it forms very 
weak complexes (Ka ~10 M-1) because the αCD cavity is too small for efficient 
complexation.[20] We hypothesized that hydrogels functionalized with βCD but not αCD 
would efficiently bind hydrocortisone through inclusion complexation. We further 
predicted that hydrogels functionalized with βCD and inhibited with adamantane 
carboxylic acid would be unable to bind hydrocortisone. Experimental confirmation of 
these hypotheses will prove that our HA-βCD hydrogels bind drug by inclusion 
complexation. 
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3.2 Results  
3.2.1 Characterization of methacryloyl-cyclodextrin. To make drug-binding GMHA 
hydrogels we first needed to synthesize a polymerizable βCD monomer. A methacryloyl-
cyclodextrin monomer was synthesized by the base-catalyzed reaction of βCD with 
methacrylic anhydride (Figure 3.2). The reaction of methacrylic anhydride with βCD 
may occur at any of the 21 hydroxyls and produces a mixture of methacryloyl-β-
cyclodextrin derivatives that have different numbers of methacryloyl groups. The degree 
of substitution (DS) is defined as the moles of methacryloyl groups per mole of CD. The 
average DS of the product mixture was measured by MALDI-MS and 1H NMR. The DS 
of methacryloyl-βCD and methacryloyl-αCD was controlled by adjusting the molar 
equivalents of methacrylic anhydride to CD. Increasing the equivalents of methacrylic 
anhydride produced a product mixture with increasing methacryloyl substitution a 
decreasing proportion of unsubstituted cyclodextrin (Table I). We found that 4.7 molar 
equivalents of methacrylic anhydride per mole of βCD yielded a product (M4βCD) with 
an average DS of 3.1. Likewise, 6.4 molar equivalents of methacrylic anhydride per mole 
of αCD yielded a product (M6αCD) with an average DS of 3.4. Neither product 
contained more than a few percent of unsubstituted CD detected by MALDI-MS.  
 There were two considerations guiding the synthesis of methacryloyl-CD. First, 
the product should be free of unsubstituted CD which would be unpolymerizable. 
Second, highly substituted methacryloyl-CD should be avoided because methacryloyl 
groups may occlude CD’s cavity and inhibit complexation.[31] M4βCD and M6αCD were 
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compromises between these constraints because they contained little unsubstituted CD 
and the DS between 3 and 4 was relatively low. 
 Methacrylic acid oligomer impurities were removed from the crude product 
mixtures by reverse phase HPLC. To determine the effectiveness of HPLC purification, 
the mass and average DS were measured for each of the thirty-two eluate fractions 
(Figure 3.3). Mass recovered in the first three fractions was shown to consist of 
methacrylic oligomers by NMR. The methacryloyl-CDs eluted separately from the 
impurities and in order of increasing DS. Unsubstituted CDs and CDs with DS greater 
than six were discarded. The remaining fractions were combined and analyzed by 
MALDI-MS which showed that no unsubstituted CD remained (Figure 3.4).  The 1H 
NMR spectra of purified M4βCD has vinyl peaks at 5.6 and 6.1 ppm and a methyl peak 
at 1.9 ppm (Figure 3.5). These peaks indicate the presence of methacryloyl groups. 
Average DS values of 3.2 and 3.6 for M4βCD and M6αCD, respectively, were 
determined from NMR spectra and are consistent with MALDI measurements. 
 3.2.2 Inclusion complexes of methacryloyl cyclodextrins. Phase solubility 
diagrams were constructed to assess the strength of complexation between CD and 
hydrocortisone. A phase solubility diagram is a plot of drug solubility against CD 
concentration. The association constant, Ka, can be calculated from the slope of the 
solubility curve using Equation 2. A steep slope indicates a large Ka. Use of Equation 2 
requires the following assumptions: (i) 1:1 complexation of drug and CD; (ii) saturation 
of the solution with uncomplexed drug; (iii) equilibrium concentrations of drug, CD, and 
complex; and (iv) equivalent molar absorptivity of complexed drug and uncomplexed 
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drug at the analyzed wavelength. The Ka is a nonlinear function of the slope and is 
sensitive to small differences in concentration measurements. The Ka for hydrocortisone 
has been reported as 1720, 2683, and 4170 M-1 reflecting the variability of this 
measurement.[20,23,24]  
 The solubility curves of hydrocortisone in solutions of βCD and M4βCD are 
plotted in Figure 3.6. The Ka for βCD and M4βCD were 5422 M-1 and 1268 M-1 
respectively. The shape of the βCD solubility curve is linear at low concentrations and 
plateaus at high concentrations. Solubility curves of this shape are classified as B-type 
and they suggest the formation of soluble 1:1 complexes at low βCD concentrations and 
precipitation of insoluble complexes at high concentrations.[20,28] These results are 
consistent with previously reported βCD-hydrocortisone solubility curves.[20,23,24] The 
shape of the M4βCD solubility curve was linear throughout. Linear solubility curves are 
classified as A-type and are consistent with the formation of soluble 1:1 complexes.[20] 
The magnitude of the association constant, Ka ~103 M-1, confirms that M4βCD 
complexes effectively with hydrocortisone. The partial decrease in association constant 
for M4βCD relative to βCD may have been caused by steric hindrance by methacryloyl 
groups. Similarly, commercial hydroxypropyl derivatives of βCD have a diminished 
affinity for hydrocortisone because of steric hindrance; Ka has been reported as both 636 
M-1 and 1040 M-1.[32,33]  
 Phase solubility curves of hydrocortisone with αCD and M6αCD are plotted too 
(Figure 3.6). The Ka for αCD and M6αCD were 94 M-1 and 164 M-1 respectively. These 
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weak association constants indicate that neither αCD nor M6αCD complex effectively 
with hydrocortisone. These results are consistent with the mismatch of hydrocortisone’s 
size and the volume of αCD’s cavity. 
 3.2.3 Swelling ratios of hyaluronic acid-cyclodextrin hydrogels. Hydrogels of 
HA and CD were crosslinked by photopolymerization and swelled to equilibrium in PBS. 
The dry and swollen weights were measured by thermogravimetry. Hydrogel swelling 
was strongly dependent on cyclodextrin concentration but not cyclodextrin type (i.e., α or 
β). The close similarity in both swelling ratio and composition establishes that the 
GMHA-M4βCD and GMHA-M6αCD hydrogels are physico-chemically similar except 
for the property of CD cavity size. The volume of solvent absorbed per unit mass of 
polymer decreased with increasing concentration of cyclodextrin (Figure 3.7). Addition 
methacryloyl cyclodextrin to the GMHA matrix increases the concentration of 
methacryloyl groups and results in greater crosslink density and decreased swelling. 
These results strongly support the successful incorporation of methacryloyl-CD 
derivatives into the GMHA matrix.  
 3.2.4 Hydrocortisone uptake by hyaluronic acid-cyclodextrin hydrogels. This 
experiment measured the capability of GMHA-M4βCD hydrogels to absorb 
hydrocortisone. The molar quantity of absorbed hydrocortisone was plotted against the 
moles of hydrogel M4βCD functionalities (Figure 3.8A). This plot is analogous to the 
phase solubility diagram in Figure 3.4. Absorption in terms of mass (mg drug / g 
polymer) is also plotted (Figure 3.8B). Unfunctionalized GMHA hydrogels correspond 
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to the data points located at the y-axis intercept (i.e. hydrogels with 0 µmol of 
cyclodextrin functional groups). Unfunctionalized GMHA hydrogels absorbed 30.0 ± 2.0 
µg hydrocortisone whereas GMHA-M4βCD with the highest level of functionalization 
absorbed 79.8 ± 4.6 µg hydrocortisone. M4βCD functionalities and hydrocortisone 
uptake show a statistically strong and positive correlation (Pearson correlation 
coefficient, r = 0.972). These results demonstrate that incorporation of M4βCD 
functionalities in the GMHA hydrogel enhanced drug-hydrogel interactions and increased 
hydrocortisone loading. 
 Drug-hydrogel interactions are a complicated phenomena that depend on 
variables including the hydrogel charge density, polymer-solvent interactions, hydrogen 
bonding, and crosslink density. We wanted to determine conclusively whether inclusion 
complexation rather than any non-inclusion effect was the mechanism of increased 
hydrocortisone uptake. If inclusion complexation is indeed the dominant mechanism then 
hydrocortisone uptake should be inhibited by a strong βCD-binding ligand. Consistent 
with this hypothesis, we found that pre-incubation of GMHA-M4βCD hydrogels with 
adamantane carboxylic acid abolished all additional hydrocortisone uptake. The inhibited 
GMHA-M4βCD hydrogels absorbed only 29.3 ± 0.5 µg hydrocortisone which is 
statistically no different than pure GMHA hydrogels. The Pearson correlation coefficient, 
–0.142, further indicates that there is no correlation between M4βCD functionalities and 
hydrocortisone uptake when complexation is inhibited by adamantane carboxylic acid.  
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 The mechanism of inclusion complexation was corroborated by a second 
experiment in which parallel hydrogels of GMHA functionalized with M6αCD were 
tested for hydrocortisone absorption. Uptake by GMHA-M6αCD hydrogels should be 
substantially lower because M6αCD is less effective at hydrocortisone complexation than 
M4βCD as shown in Figure 3.6. Consistent with this hypothesis, we found that GMHA-
M6αCD hydrogels absorbed much less hydrocortisone than GMHA-M4βCD hydrogels. 
GMHA-M6αCD hydrogels absorbed up to 46.0 ± 3.1 µg hydrocortisone (equivalent to 
16.4 mg/g polymer) compared to 79.8 ± 4.6 µg hydrocortisone (equivalent to 29.3 mg/g 
polymer) for GMHA-M4βCD hydrogels. These experiments establish that inclusion 
complexation is the dominant mechanism of hydrocortisone uptake by GMHA-M4βCD 
hydrogels. 
 3.2.5 Hydrocortisone release by hyaluronic acid-cyclodextrin hydrogels. The 
stability of the hydrogel-hydrocortisone complex was assessed by examining the kinetics 
of hydrocortisone release. Four compositions of hydrogel were investigated spanning a 
range of pure GMHA to GMHA functionalized with 14 mg/mL M4βCD. The hydrogels 
containing more M4βCD functionalities released more hydrocortisone as was expected 
(Figure 3.9A). The duration of release was modestly but significantly extended by 
increasing M4βCD functionalization (ANOVA, α=0.05). The pure GMHA hydrogels 
released 100% of hydrocortisone within the first hour whereas the GMHA hydrogels with 
14 mg/mL M4βCD released only 70% (Figure 3.9B). Cyclodextrin functionalization 
enhanced drug loading but had little effect on the kinetics of release. 
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3.3 Discussion 
 Drug loading of a hydrogel is dependent on the solubility of drug in the absorbed 
solvent and by interactions of drug with the polymer.[34] We engineered HA hydrogels 
with enhanced drug-polymer interactions by incorporating a functional βCD monomer. 
This permitted the hydrogels to uptake more hydrocortisone from aqueous solution. An 
important aspect of this work is that the mechanism of absorption was unambiguously 
established as inclusion complexation. Confirmation of the mechanism of drug loading is 
necessary to rationally optimize the hydrogels and further engineer them for target 
applications.  
 The slope of the GMHA-M4βCD line in Figure 3.8A is 0.156 µmol 
hydrocortisone per µmol M4βCD. This indicates that about 1 in 6 of the hydrogel 
M4βCD moieties formed inclusion complexes; therefore, hydrogel M4βCD was less 
efficient at complexation than soluble M4βCD. This difference may be explained because 
hydrocortisone must first partition into the gel phase before complexing with hydrogel 
M4βCD functionalities. Methods that shift cyclodextrin-drug equilibrium towards 
complexation (e.g., lyophilization, kneading, spray-drying) can be used to prepare 
M4βCD-hydrocortisone complexes prior to photopolymerization and circumvent the gel 
phase barrier of post-gelation complexation.[35]  
 The time release profiles of hydrocortisone from GMHA-M4βCD hydrogels are a 
preliminary assessment of the stability of the hydrogel-drug complexes. The release 
profiles were similar in terms of percent release across all four hydrogel compositions 
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despite that the mass of hydrocortisone released was very different. Thus the amount of 
hydrocortisone delivered by GMHA-M4βCD hydrogels can be tuned without altering the 
kinetics of release under these conditions. For a given application it may be desirable to 
prepare drug-loaded GMHA-M4βCD hydrogels in a dried state; therefore, the kinetics of 
release could be very different from the kinetics observed here for which solvent 
penetration and hydrogel swelling played no role.  
 Biomedical applications of HA hydrogels include drug delivery, adhesion 
barriers, wound dressings, dermal fillers, and tissue engineering scaffolds that could 
benefit from the capability to locally deliver bioactive agents. GMHA-M4βCD hydrogels 
may be engineered to fit the requirements of such applications. The model drug used in 
these experiments, hydrocortisone, is structurally similar to a large number of steroidal 
drugs that can be expected to complex with the GMHA-M4βCD hydrogel. Furthermore, 
any of the great number of drugs known to complex with βCD may complex with these 
hydrogels. Development of peptide and protein complexation with GMHA-M4βCD 
hydrogels will further expand the versatility of the hydrogels and adapt them more fully 
to tissue engineering applications. It is possible to synthesize HA hydrogel microparticles 






3.4 Materials and Methods 
 3.4.1 Materials. High molecular weight sodium hyaluronate from Streptococcus 
equi of molecular weight 1.6x106 Da was obtained from Sigma-Aldrich (St. Louis, MO). 
Dialysis tubing was obtained from Spectrum Laboratories Inc. and Irgacure 2959 was 
obtained from Ciba Specialty Chemicals (Basel, Switzerland). All other chemicals and 
reagents were obtained from Sigma-Aldrich. Circular silicone rubber molds (Grace Bio-
Labs, Bend, OR) of 9 mm diameter and 2 mm thickness were used for making hydrogels. 
A longwave UV lamp filtered around 365 nm and with an intensity of 22 mW/cm2 was 
used to initiate photopolymerization (Blak-Ray B-100A, UVP, Upland, CA).  
 3.4.2 Synthesis of methacryloyl cyclodextrin. A 15 mM solution of cyclodextrin 
was prepared in deionized, distilled water. Methacrylic anhydride was added dropwise 
and 10 M sodium hydroxide was added to adjust the pH to 8.0. The solution was stirred 
and the pH was continually adjusted for 6 hours until the pH stabilized. The reaction 
mixture was then transferred to cellulose ester dialysis tubing of 500 molecular weight 
cut-off and dialyzed against deionized distilled water for 48 hours. The dialyzed solution 
was frozen in liquid nitrogen and lyophilized.  
 3.4.3 HPLC purification of methacryloyl-cyclodextrin. Crude methacrylated 
CD was purified by reverse phase HPLC with an ÄKTA Purifier and Source 5RPC ST 
4.6/150 column (Amersham Pharmacia Biotech, Piscataway, NJ). A linear gradient of 
98:2 to 45:55 water-acetonitrile and flowrate 0.8 mL/min was used for the mobile phase. 
The injection volume was 1 mL of 100 mg/mL solution. The recovered purified product 
was lyophilized and stored dessicated in the dark until use. 
 To assess the efficacy of the separation, the HPLC eluate was collected in thirty-
two 1 mL fractions. The collection tubes were weighed before collection. After collection 
the fractions were lyophilized to dryness and reweighed to determine the mass recovered 
in each fraction. Fractions were screened by MALDI-MS to detect the presence of 
cyclodextrins. The purified M4βCD and M6αCD used in subsequent experiments 
consisted of fractions 8-22 and 7-22, respectively. 
 3.4.4 NMR and MALDI. 1H NMR samples were dissolved in deuterium oxide 
and the spectra recorded on a Varian Unity +300 spectrometer. The degree of substitution 
(DS) was calculated by integration of all cyclodextrin 1H peaks (49 H atoms) and 
integration of the vinyl peaks at 5.6 and 6.1 ppm (2 H atoms). Matrix-assisted laser 
desorption/ionization mass spectrometry (MALDI-MS) was also used to characterize the 
DS of derivatized cyclodextrin.[25-27] Spectra were recorded with a PerSeptive Biosystems 
Voyager MALDI-MS instrument. The matrix solution was 2.5 mg/mL α-cyano-
hydroxycinammic acid in 50:50 water:acetonitrile and was spotted in equal volumes with 
aqueous CD solutions. Methacryloyl cyclodextrins were detected in positive ion mode as 
singly charged sodium adducts that were separated by 68 m/z which corresponds to the 
molecular weight of one methacryloyl-group. The average DS of the product mixtures 
was calculated from MALDI-MS spectra by Equation 1, where I is the intensity measured 
by peak height and d.s. is the degree of substitution corresponding to the peak. 





                      [1] 
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 3.4.5 Phase solubility diagrams. Phase solubility diagrams were constructed by 
the method of Higuchi and Connors to determine the association constants of native αCD 
and βCD, and of their methacrylated derivatives.[28] Triplicate samples of 300 µL of 
aqueous CD solutions were prepared in 0.65 mL tubes. An excess of hydrocortisone (~5 
mg) was added to each sample. The solutions were sonicated for 5 minutes and then 
incubated at room temperature and rotated end over end for 6 days to achieve equilibrium 
concentrations of hydrocortisone, CD and complex. After 6 days the solutions were 
syringe filtered to remove undissolved solid phase hydrocortisone. The filtrate was 
diluted and the absorbance measured at 248 nm. This absorbance is a measure of the total 
concentration of hydrocortisone in both the complexed and uncomplexed form. The 
concentration of hydrocortisone was plotted against the concentration of CD and a 
regression line was fit to the linear portion of each solubility curve. The association 
constant was calculated from the slope of the regression line according to Equation 2, 
where Ka [M-1] is the association constant and C0 [1.04 x 10-3 M] is the solubility of 
hydrocortisone in water determined by experiment. 
     
0)1( Cslope
slopeK a −
=                                    [2] 
 3.4.6 Methacryloyl modification of hyaluronic acid. Hyaluronic acid was 
conjugated with photopolymerizable methacryloyl groups following a modified protocol 
of a procedure described previously.[29] A 1% w/v solution of HA was prepared in a 
50:50 mixture of acetone:water and stirred 24 hours. Twenty molar equivalents of 
triethylamine as base catalyst and twenty molar equivalents of glycidyl methacrylate 
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were added to the solution and stirred for 24 hours at room temperature. The glycidyl 
methacrylate-modified hyaluronic acid (GMHA) was precipitated into a 20-fold 
volumetric excess of acetone, dissolved in water, precipitated a second time, redissolved 
in water, and lyophilized. The average degree of methacrylate substitution was 
determined by 1H NMR and was 0.32 moles of methacryloyl groups per mole of HA 
disaccharides.  
 3.4.7 Hydrogel swelling ratio measurements. Gelation solutions of 20 mg/mL 
GMHA and 5, 10 or 15 mg/mL M4βCD and M6αCD were prepared in phosphate 
buffered saline (PBS, 10 mM, pH 7.4) containing 1% w/v Irgacure 2959 and 0.3% N-
vinyl pyrrolidone. Hydrogels were each prepared from 100 µL of gelation solution and 5 
minutes of UV exposure. The hydrogels were then swelled to equilibrium in PBS and 
rinsed with several exchanges of PBS to remove photoinitiator. A small portion of each 
swollen gel, 10-15 mg, was placed in a thermogravimetric analyzer (Perkin Elmer TGA 
7) and heated at 100°C until all water was evaporated and a constant dry weight was 
obtained. The mass of residual PBS salts contributing to the dry weight was determined 
from the mass of evaporated water and was subtracted to obtain the dry weight of the 
polymer alone. The swelling ratio was calculated according to Equation 3, where SR [g 
PBS / g polymer] is the swelling ratio, WS [g] is the swollen weight of the hydrogel, and 
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 3.4.8 Uptake of hydrocortisone by GMHA hydrogels. These experiments 
assessed the GMHA-M4βCD hydrogel’s ability to uptake hydrocortisone. Pre-gelation 
solutions of 20 mg/mL GMHA and 3-15 mg/mL M4βCD and M6αCD were prepared in 
phosphate buffered saline (PBS) containing 1% w/v Irgacure 2959. Eight hydrogels per 
composition were prepared with 80 µL of pre-gelation solution and 5 minutes of UV 
exposure. Hydrogels were swollen to equilibrium in PBS and rinsed with several 
exchanges of PBS to remove photoinitiator. Hydrogels were then incubated at room 
temperature for 7 days in 3 mL of PBS saturated with hydrocortisone. To determine the 
amount of hydrocortisone uptake the hydrogels were transferred to fresh PBS and placed 
on an orbital platform for release for 48 hours. The concentration of released 
hydrocortisone in the buffer was determined spectrophotometrically. 
 An additional experiment tested whether adamantane carboxylic acid could 
inhibit hydrocortisone uptake by binding βCD functionalities. GMHA-M4βCD hydrogels 
were each pre-incubated in 3 mL of PBS saturated with adamantane carboxylic acid for 
48 hours and then transferred to PBS saturated with both hydrocortisone and adamantane 
carboxylic acid and incubated for 7 days. These hydrogels were transferred to fresh PBS 
and the concentration of released hydrocortisone was determined spectrophotometrically.  
 3.4.9 Release of hydrocortisone from GMHA hydrogels. The stability of the 
hydrogel-hydrocortisone complexes was assessed by examining the kinetics of 
hydrocortisone release into PBS buffer at 37°C. Six hydrogels per composition were 
prepared as described previously for the uptake experiment. Gels were rinsed thoroughly 
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to remove photoinitiator and then incubated for 1 week in PBS saturated with 
hydrocortisone. After incubation the gels were transferred to Eppendorf tubes containing 
15 mL of PBS. The tubes were incubated at 37°C and rotated end over end. Aliquots of 
500 µL were collected from each sample at each time point and replaced with 500 µL of 
fresh buffer.  
 The concentration of released hydrocortisone in each aliquot was measured by 
HPLC.[30] The column was a Waters Spherisorb ODS1 column with diameter 4.6 mm, 
length 150 mm, and 5 µm particles (Waters Corporation, Milford, MA). The mobile 
phase was 60/40 methanol/water at flowrate of 1 mL/min. Hydrocortisone was detected 
at 245 nm and had a retention time of 4.6 minutes. Injection volume was 25 µL. The 
equipment was a Waters Dual HPLC Pump 515, Waters 996 Photodiode Array Detector, 
and Waters 717 Plus Autosampler. The concentration of hydrocortisone was calculated 
by peak area using Waters Empower Pro Software. A series of seven standards spanning 
the full range of hydrocortisone concentrations was analyzed at the beginning and end of 
the assay and  confirmed the linearity and stability of the assay. 
 3.4.10 Statistical analysis. Regression lines, Pearson correlation coefficients (r), 
and 95% confidence intervals (95% CI) were calculated with SPSS 14.0 software (SPSS 
Inc., Chicago, IL). Slopes of the regression lines are given as slope ± standard error. All 
other results are reported as mean ± standard deviation. Significant differences in the 
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Figure 3.3 Purification of (A) M4βCD and (B) M6αCD by reverse phase HPLC. Bars 
are the weight percentage of total recovered mass in each fraction of eluate. The dark 
solid line is the average degree of substitution of cyclodextrin in each fraction as 
determined by MALDI-MS. The light line is the absorbance chromatogram. The 
methacrylic oligomer impurities eluted in fractions #1-3 and the methacryloyl 














Figure 3.4 MALDI-MS spectra of (A) crude M4βCD; (B) crude M6αCD; (C) purified 
M4βCD and (D) purified M6αCD. The peaks are labeled with the degree of substitution. 
Peaks correspond to singly charged sodium adducts of cyclodextrin and are separated by 
68 m/z which is the molecular weight of one methacryloyl-group. Unsubstituted 
cyclodextrin (DS 0) and small amounts of highly substituted cyclodextrin (DS > 6) were 










Figure 3.5 1H NMR spectra of (A) βCD; (B) crude M4βCD; (C) methacrylic impurities; 
and (D) purified M4βCD. Vinyl (5.6 and 6.1 ppm) and methyl (1.9 ppm) peaks in the 
spectra of M4βCD indicate the presence of methacryloyl groups. All of the impurity 


































Figure 3.6 Phase solubility diagram of hydrocortisone with underivatized and derivatized 
cyclodextrins. Association constants were calculated from the linear portions of each 
curve. (♦) βCD, Ka = 5422 M-1; 95% confidence interval (CI) = [4484, 6750]; (▲) 
M4βCD, Ka = 1268 M-1, 95% CI = [1149, 1408]; (■) αCD, Ka = 94 M-1, 95% CI = [86, 
104]; (x) M6αCD, Ka = 164 M-1; 95% CI = [159, 169]. Data points are mean ± standard 














Figure 3.7 Swelling ratio in phosphate buffered saline (PBS) as a function of 
cyclodextrin concentration. Hydrogels were composed of 20 mg/mL GMHA 
functionalized with 0, 5, 10 or 15 mg/mL M4βCD (▲) or M6αCD (∆). These data 
demonstrate that hydrogel swelling was dependent on cyclodextrin concentration but not 







Figure 3.8 Hydrocortisone absorption by hyaluronic acid-cyclodextrin hydrogels. (◊) 
GMHA-M4βCD, slope ± standard error = 0.156 ± 0.006, Pearson correlation coefficient 
(r) = 0.972; (□) GMHA-M6αCD, m = 0.040 ± 0.003, r = 0.872; (∆) GMHA-M4βCD 
inhibited with adamantane carboxylic acid, m = -0.002 ± 0.002, r = -0.142. (A) 
Hydrocortisone uptake in moles is plotted against moles of cyclodextrin functional 
groups. The slope of the regression line represents the additional moles of hydrocortisone 
absorbed by the hydrogel per mole of cyclodextrin functional groups. (B) The drug 
loading of hydrocortisone is plotted against moles of cyclodextrin hydrogel 






Figure 3.9 Release of hydrocortisone from GMHA-M4βCD hydrogels in terms of (A) 
mass and (B) % release. Hydrogel compositions are (□) 20 mg/mL GMHA;  (■) 20 
mg/mL GMHA with 3 mg/mL M4βCD; (◊) 20 mg/mL GMHA with 9 mg/mL M4βCD; 
(x) 20 mg/mL GMHA with 14 mg/mL M4βCD. The compositions with greater 
cyclodextrin functionalization released more hydrocortisone as shown in (A) and this had 
a modest but statistically significant effect (ANOVA, α=0.05) on the duration of release 
as shown in (B). Data points are mean ± standard deviation of six measurements. 
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Table I. Degree of substitution of methacryloyl-cyclodextrin and the percentage of 
unreacted cyclodextrin. 
Average Average





       
Crude Products      
 M4αCD α 4.2 2.6 4 -- 
 M6αCD #1 α 6.4 3.4 2 -- 
 M6αCD #2 α 6.4 3.3 1 -- 
 M9αCD α 9.6 4.8 0 -- 
       
 M4βCD #1 β 4.7 3.1 3 -- 
 M4βCD #2 β 4.7 3.1 3 -- 
 M4βCD #3 β 4.7 3.0 5 -- 
 M7βCD β 7.1 4.2 1 -- 
 M10βCD β 10.6 5.2 0 -- 
       
Purified Products 
     
 M6αCD #1 α 6.4 3.6 0 3.1 
 M4βCD #1 β 4.7 3.2 0 3.2 
              
CD = cyclodextrin. 
MA = methacrylic anhydride. 
DS = degree of substitution (moles of methacryloyl groups per mole of cyclodextrin). 
a Numbers after the codenames M6αCD and M4βCD denote individual batch numbers 
and show reproducibility of the synthesis.  
b Calculated from MALDI mass spectra. 













Chapter 4: Super-Swelling and Dual-Crosslinked Hydrogels of 
Hyaluronic Acid with Patterned Anisotropic Swelling 
 
Abstract 
In this chapter, we have engineered dual-crosslinked hyaluronic acid hydrogel scaffolds 
with novel anisotropic swelling which yields a new, unexplored type of shape changing 
tissue engineering scaffold. First, we synthesized super-swelling chemically crosslinked 
hyaluronic acid hydrogels. When these hydrogels were placed in solution they absorbed 
water and swelled to a great extent while faithfully maintaining their original shape. 
There is an inverse relationship between the crosslink density and swelling of a hydrogel. 
We found that adding photocrosslinks to chemically crosslinked super-swelling 
hydrogels yielded a greater crosslink density and diminished swelling. A hydrogel with 
anisotropic swelling was obtained by spatially patterning the photocrosslinks. The 
photopatterned regions exhibited low swelling because they contained both 
photocrosslinks and chemical crosslinks. The non-photopatterned regions exhibited high 
swelling because they contained only chemical crosslinks. When an unswelled dual-
crosslinked hydrogel is placed in solution it swells anisotropically because of differential 
swelling between the high and low swelling regions. This differential swelling produces a 
dynamic pattern of crosslink density, water content, and viscoelasticity at the macro- and 




TE scaffolds of HA are being developed for cartilage, skin, adipose, and other 
tissues; however, regeneration of fully natural tissue is not yet possible.[1-4] The purpose 
of a tissue engineered (TE) scaffold is to provide a support structure that can replace, 
repair, or aid in the regeneration of damaged tissue. Currently existing TE scaffolds are 
structurally simple and have homogeneous bulk properties that are unable to induce cells 
to regenerate architecturally complex healthy tissue. Thus, there is a need for methods 
that can replicate the structural complexity of natural tissues within TE scaffolds. For 
example, engineered skin substitutes are effective at performing the barrier function of 
skin but suffer from impaired vascularization and enervation and are unable to support 
the regeneration of hair follicles, sweat glands, and natural appearing pigmentation.[5] 
Injectable HA gels can fill tissue defects, but their effect is temporary because they are 
gradually resorbed without replacement by regenerated adipose tissue.[6] A limiting factor 
is the incongruence between the homogeneous structures of TE scaffolds and the 
complex patterns of mechanical properties, water content, porosity, and chemical ligands 
within natural tissues. A challenge for the next generation of TE scaffolds is to 
incorporate biomimetic spatial patterns of these properties.  
Several of the techniques that have been developed to address this challenge share 
a strategy in which a homogeneous bulk hydrogel is used as a foundational material 
within which photopatterning is used to obtain spatial distributions of material properties. 
For example, a homogeneous agarose gel modified with photolabile 2-nitrobenzyl-
cysteine functionalities was photopatterned with the cell-adhesive peptide motif, RGD, to 
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guide neurite infiltration.[7] In another example, a homogeneous poly(ethylene glycol) 
diacrylate (PEGDA) hydrogel was photopatterned with a second interpenetrating network 
of photocrosslinked PEGDA to produce spatially defined regions of high and low 
crosslink density, porosity, and diffusion.[8] Our dual-crosslinking approach is 
differentiated from this previous work because we perform the photopatterning step 
before the hydrogel is fully swelled. Thus, our dual-crosslinked hydrogels have patterned 
regions of high and low crosslink density, porosity, and diffusion that changes 
dynamically during anisotropic swelling. 
The first element of our anisotropic hydrogel design is a homogeneous base 
hydrogel of chemically crosslinked HA. The most common crosslinking agents are 
diglycidyl ethers,[9-11] divinyl sulfone,[12-14] and glutaraldehyde.[15,16] We selected 
butanediol diglycidyl ether (BDDE) because it is less toxic than other crosslinking 
agents. BDDE is a bifunctional crosslinker that reacts with HA’s primary hydroxyls. 
Crosslinking is accomplished by mixing HA with BDDE in aqueous solution and 
appropriately adjusting the temperature and pH. The reaction of HA with BDDE is 
analogous to the reaction of HA with glycidyl methacrylate. In both instances, the 
glycidyl functionalities are attacked by base activated hydroxyls on HA (chemical 
structures are depicted in Figure 4.1).  
Concentrations of HA hydrogels are typically limited to less than 2% w/v because 
higher concentrations are too viscous for adequate mixing. At very high concentrations, 
such as 10% and 20% w/v, HA solutions solidify and can neither be mixed nor poured. 
We circumvented the problem of HA’s viscosity by preparing individual hydrogels from 
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lyophilized high molecular weight HA powder sealed within silicone rubber molds 
(Figure 4.2). The crosslinker solution, consisting of BDDE and sodium hydroxide, was 
injected through the rubber mold and rapidly dissolved the HA powder. By this method 
semisolid 10% w/v solutions of high molecular weight HA were obtained in the shape of 
simple disc molds. Chemical crosslinking was initiated by placing the solutions in an 
oven and incubating for 8 hours at 40°C.  
 
4.2 Results  
4.2.1 Chemically crosslinked HA hydrogels. Chemically crosslinked HA hydrogels 
were synthesized from concentrated high molecular weight HA. Simple disc molds were 
used to prepare hydrogels for swelling, rheology, and degradation experiments. The 
representative super-swelling hydrogels depicted in Figure 4.3a were prepared from 10% 
w/v HA crosslinked with 250 µL BDDE/g HA. Before swelling, the hydrogel matched 
the size of the mold. When the hydrogel was swollen in saline it absorbed 100 times its 
weight of solution. When the hydrogel was swollen in deionized distilled water it 
absorbed 1000 times its weight while retaining the disc shape. 
 It was surprising to find that the super-swelling HA hydrogels maintained their 
original shape even after swelling so extensively. We are interested in bulk hydrogels that 
have defined shapes and structures to be used as TE scaffolds. To test shape retention of a 
complex structure, we created hand-shaped PDMS molds. HA hydrogels were chemically 
crosslinked within the hand molds and then swelled in water and saline. The super-
swelling hydrogels successfully preserved the complex hand shape even while swelling 
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to many times their original size (Figure 4.3b). Ideally, a TE scaffold should be 
implantable through a small surgical incision and expand in vivo to conform to the shape 
of a tissue defect. The super-swelling property of these HA hydrogels and their ability to 
maintain shape addresses this issue.  
 The swelling ratio is an indirect measure of the extent of crosslinking and, for a 
given hydrogel system, the swelling ratio will decrease as the extent of crosslinking 
increases. The swelling behavior of these HA hydrogels was dependant on the 
concentrations of HA and BDDE (Figure 4.4). Increasing concentrations of BDDE and 
HA produced hydrogels with less swelling. The equilibrium swelling ratio of 10% HA 
hydrogels decreased from 2600 g water/g polymer to 400 g/g when the volume of 
crosslinker was increased from 150 µL/g to 500 µL/g. The swelling ratios of 10% and 
20% w/v HA hydrogels differed by an order of magnitude. The swelling ratio of 20% HA 
hydrogels decreased from 105 g/g to 24 g/g when the volume of crosslinker was 
increased from 150 µL/g to 500 µL/g. The swelling ratio of the HA hydrogels in water is 
the maximum attainable swelling; but swelling in saline more closely resembles in vivo 
conditions. The time profiles of 10% HA hydrogels in saline reveal that they swell 
rapidly during the first 8 hours and then swell slowly (Figure 4.5). Equilibrium swelling 
was achieved within 48 hours for 10% hydrogels. The lesser swelling 20% hydrogels 
reached equilibrium swelling within 10 hours. 
 Rheological characterization of the chemically crosslinked hydrogels was 
performed to examine the effect of crosslinking on hydrogel stiffness. All rheological 
measurements were performed on hydrogels at equilibrium swelling in saline. The 
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storage modulus was plotted as a function of frequency (Figure 4.6). There is a 
pronounced increase in the storage modulus with increasing BDDE concentrations 
because a higher degree of crosslinking increased the stiffness of the hydrogels. Among 
10% w/v hydrogels, the moduli of 500 µL/g hydrogels are almost two orders of 
magnitude greater than the 150 µL/g hydrogels. Furthermore, as the HA concentration 
increases from 10% to 20% w/v, the value of G′ becomes much greater. The increase in 
HA concentration results in denser crosslinking and greater entanglement. Thus, the 
rigidity of the hydrogel is dependent on both polymer concentration and crosslinker 
concentration.  
The degradation of chemically crosslinked hydrogels was performed with 
hyaluronidase, a mammalian enzyme that acts upon HA in vivo. Among chemically 
crosslinked hydrogels, the degradation rate decreased with an increase in BDDE 
concentration (Figure 4.7). Furthermore, the degradation rate was considerably less for 
20% w/v HA concentrations compared to 10% w/v concentrations. The results of the 
swelling, rheological, and degradation studies of the chemically crosslinked hydrogels 
demonstrate that increasing crosslink density produces hydrogels with less swelling, 
greater storage moduli, and slower rates of degradation.  
 4.2.2 Photocrosslinked HA hydrogels. The next element of our design was to 
introduce photocrosslinks into the super-swelling chemically crosslinked hydrogels. For 
this purpose, we synthesized a glycidyl methacrylate derivative of hyaluronic acid 
(GMHA).[17] GMHA has pendant methacrylate functionalities that can be polymerized by 
mixing GMHA with photoinitiator and exposing to UV light. The photocrosslinks consist 
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of polymethacrylate chains linked to many HA chains. Spatial control of 
photocrosslinking is possible with the use of photomasks.[7,18]  
 The conditions of photocrosslinking were optimized to minimize hydrogel 
swelling (Figure 4.8). Irgacure 2959 is among the most biocompatible of photoinitiators 
yet exhibits cytotoxicity at sufficiently high concentrations;[19,20] therefore, an optimum 
photoinitiator concentration is the minimum that is required for maximal crosslinking 
inferred from the swelling ratio. The swelling ratio was found to be largely independent 
of photoinitiator concentration over the range of 0.05-1.0% w/v; thus, the least 
concentration tested, 0.05% w/v, was selected for further experiments. Hydrogel swelling 
was strongly dependent on UV exposure for durations less than 5 minutes but not for 
durations greater than 5 minutes. This indicates that most crosslinks are formed within 
the first 5 minutes of UV exposure and this time was selected as the optimum duration. 
 The effects of these two parameters, photoinitiator concentration and UV 
exposure time, on the rate of degradation were examined. These two parameters impact 
the crosslink density and therefore should impact the degradation rate. Five combinations 
of photoinitiator concentration and UV exposure were examined by enzymatic 
degradation. Among these hydrogels, the combination (1% photoinitiator and 0.5 min 
UV) with the fastest rate of degradation exhibited the greatest swelling (Figure 4.9). The 
combination (1% photoinitiator and 20 min UV) with the slowest rate of degradation 
exhibited the least swelling. All hydrogels were degradable by hyaluronidase and 
therefore should degrade in vivo. After investigating the synthesis conditions of 
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chemically-crosslinked and photocrosslinked hydrogels individually, we turned our 
attention to dual-crosslinked hydrogels. 
 4.2.3 Dual-crosslinked HA hydrogels. Dual-crosslinked hydrogels possess two 
kinds of crosslinks: chemical crosslinks and photocrosslinks. First, photocrosslinks are 
formed by exposure to UV light and then chemical crosslinks are formed by adjusting the 
pH and temperature (see schematic in Figure 4.1c). To investigate the contributions made 
by chemical crosslinks and photocrosslinks to the viscoelastic properties of dual-
crosslinked hydrogels, rheological comparisons were made among the following samples: 
(i) dual-crosslinked hydrogels; (ii) chemically crosslinked hydrogels; and (iii) 
photocrosslinked hydrogels. The individual contributions of photocrosslinks and 
chemical crosslinks to the viscoelasticity of dual-crosslinked hydrogels are depicted in 
the plot of storage modulus and loss modulus in Figure 4.10. The dual-crosslinked 
hydrogels exhibited a greater storage modulus (1370 Pa) than either chemically 
crosslinked hydrogels (450 Pa) or photocrosslinked hydrogels (140 Pa). This 
demonstrates that the two crosslinking methods are synergistic and were combined within 
the dual-crosslinked hydrogel to obtain a greater crosslink density and viscoelasticity.  
 Chemical crosslinking, but not photocrosslinking, requires alkaline pH and 
elevated temperatures. For consistency, the photocrosslinked hydrogels in this 
rheological experiment were exposed to eight hours of alkaline pH and elevated 
temperature to match the synthesis conditions of the dual-crosslinked and chemically 
crosslinked hydrogels. Therefore, the differences in viscoelastic properties in Figure 4.10 
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reflect the effect of crosslink density alone and not incidental degradation by different 
temperature and pH treatments. 
 The dual-crosslinking method was adapted to photopatterning by use of a 
photomask. There are two kinds of regions in patterned dual-crosslinked hydrogels: (i) 
high-swelling chemically crosslinked regions and (ii) low-swelling dual-crosslinked 
regions. We created a patterned dual-crosslinked hydrogel in which half was exposed to 
UV and half was unexposed. This hydrogel exhibited anisotropic swelling when swollen 
to equilibrium in saline (Figure 4.11). The high swelling chemically crosslinked region 
swelled expansively and the low swelling dual-crosslinked region swelled very little. The 
differential swelling caused distortions in the shape of the hydrogel because the high 
swelling chemically crosslinked region was partially restrained by the adjacent low 
swelling dual-crosslinked region. The two regions of the patterned dual-crosslinked 
hydrogels tended to fracture when the degrees of swelling were highly mismatched.  
 Fluorescent labeling by fluorescein-acrylate was used to visualize 
photopatterning. The dual-crosslinked regions fluoresced green because fluorescein-
acrylate was incorporated into the polymethacrylate photocrosslinks during UV-initiated 
radical polymerization. Dual-crosslinked hydrogels were patterned on the micro-scale 
with a stereolithography system and digital micro-mirror array.[21] A hexagonal lattice 
photomask was used to pattern anisotropic swelling hydrogels in which low swelling 
dual-crosslinked regions coincided with the lattice and high-swelling regions coincided 
with the interstices. The unswelled dual-crosslinked hydrogel possessed a featureless flat 
surface; however, when placed in a solution the featureless surface evolved a series of 
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regularly repeating bumps that were induced by anisotropic swelling (Figure 4.11d). 
These patterned hydrogels demonstrate that the dual-crosslink methodology can produce 
continuous bulk materials with macro- and micro-scale distributions of crosslink density, 
water content, and viscoelasticity. Furthermore, these hydrogels can contort into 
predefined shapes upon contact with water. 
 
4.3 Discussion 
 Others have reported a method for producing anisotropically swelling hydrogel 
constructs by using soft lithography to stamp bilayer films of swellable poly(methacrylic 
acid) and non-swellable poly(hydroxyethyl methacrylate).[22] In solution the swellable 
layer curled around the edges of the non-swellable layer to produce a folding hydrogel 
that could grip tissue surfaces. In our method we use two modes of crosslinking within a 
single continuous hydrogel to achieve anisotropic swelling of a bulk three-dimensional 
structure. Our material of choice is HA which is well suited to biomedical and tissue 
engineering applications. We confirmed that the hydrogels were enzymmatically 
biodegradable by hyaluronidase; thus, our anisotropically swelling hydrogels are entirely 
composed of a biodegradable and non-immunogenic biopolymer. 
 Future refinement of anisotropically swelling and super-swelling HA hydrogels 
should be directed toward three goals. The first goal is a tunable rate of swelling. A 
hydrogel that swells quickly can rapidly imbibe water that supports mechanical stability. 
Fast-swelling superabsorbent hydrogels of polyacrylate and other synthetic monomers 
have been cleverly designed by introducing macropores through acid foaming of 
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effervescent sodium bicarbonate salts.[23] Macropores facilitate the influx of water and 
increase the rate of swelling; however, this method is not directly applicable to HA 
hydrogels because HA is acid sensitive and its solutions are highly viscous. Therefore, 
inventing a compatible method for creating macropores within HA hydrogels is 
necessary. The second goal is an environmental stimulus to trigger swelling. Currently, 
these HA hydrogels begin to swell immediately upon contact with water. Triggered 
swelling would permit the unswelled hydrogels to be easily rinsed, neutralized, and 
further processed ex vivo prior to implantation and triggered swelling in vivo. The third 
goal is a method for preventing the fracture of dual-crosslinked hydrogels at interfaces 
between high and low swelling regions. Addition of a fibrillar component to hydrogels 
may relieve some of the tensile stresses that can cause mechanical failure. This is 
analogous to the collagen fibers in cartilage that are the natural source of tensile strength 
that complements the compressive strength of HA.[24]  
 In conclusion, we have found that crosslinking concentrated solutions of HA with 
BDDE yields super-swelling hydrogels that greatly increase in size and maintain their 
initial shape. The addition of photocrosslinks to these super-swelling hydrogels increased 
the crosslink density and diminished swelling. Patterning of the photocrosslinks produced 
dual-crosslinked anisotropically swelling hydrogels. Unswelled dual-crosslinked 
hydrogels in solution swell and contort into new predefined shapes due to the differential 
swelling between photopatterned regions. This dual-crosslink methodology expands the 




4.4 Materials and Methods 
 4.4.1 Materials. High molecular weight sodium hyaluronate from Streptococcus 
equi of molecular weight 1.6x106 Da was obtained from Sigma-Aldrich (St. Louis, MO). 
Photoinitiator Irgacure 2959 (I2959) was obtained from Ciba Specialty Chemicals (Basel, 
Switzerland). Bovine testicular hyaluronidase of 999 U/mg and all other chemical 
reagents were obtained from Sigma-Aldrich. Circular silicone rubber molds (Grace Bio-
Labs, Bend, OR) of 8 mm diameter, 2 mm thickness, and 100 µL volume were used for 
making hydrogels. A longwave UV lamp filtered around 365 nm and with an intensity of 
22 mW/cm2 was used to initiate photopolymerizations (Blak-Ray B-100A, UVP, Upland, 
CA).  
 4.4.2 Methacryloyl modification of hyaluronic acid. HA was conjugated with 
photopolymerizable methacryloyl groups following a protocol that has been described 
previously with modifications.[25] A 1% w/v solution of HA was prepared in a 50:50 
mixture of acetone:water and stirred 24 hours. Twenty molar equivalents of triethylamine 
as base catalyst and glycidyl methacrylate were added to the solution and stirred for 24 
hours at room temperature. The glycidyl methacrylate modified hyaluronic acid (GMHA) 
was precipitated into a 20-fold volumetric excess of acetone, dissolved in water, 
precipitated a second time, redissolved in water and lyophilized. The dry GMHA product 
was dessicated and stored at –20 °C in the dark until use. The average degree of 
methacrylate substitution was determined by 1H NMR and found to be 0.32 moles of 
methacryloyl groups per mole of HA disaccharides.  
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 4.4.3 Synthesis of chemically crosslinked hydrogels. These hydrogels were 
prepared by the method depicted in Figure 4.2a. For each hydrogel either 10 mg or 20 mg 
of sodium hyaluronate powder were dispensed into a circular silicone rubber mold. The 
molds were sandwiched between two glass microscope slides and tightly secured. 
Crosslinking solutions consisted of 0.2 M NaOH containing butanediol diglycidyl ether 
(BDDE). This solution was injected through the side of each rubber mold by a syringe 
equipped with a 25 gauge needle. A second needle provided an exit for air and care was 
taken to minimize entrapment of bubbles. A volume of crosslinking solution was added 
to completely fill each mold. The molds were approximately 100 µL in volume and 
yielded an HA concentration of 10% or 20% w/v. HA and crosslinking solution were 
then incubated at 40°C for eight hours. The crosslinked hydrogels were removed from the 
molds and transferred to a large volume of either distilled deionized (ddI) water or saline 
(0.9% NaCl) for swelling. 
 4.4.4 Synthesis of photocrosslinked hydrogels. These hydrogels were prepared 
by the method depicted in Figure 4.2b. For each hydrogel an appropriate mass of GMHA 
was placed into a silicone rubber mold. The mold was secured between two glass 
microscope slides. Crosslinking solutions consisted of aqueous solutions of 0.05–1.0% 
w/v I2959. 100 µL of crosslinking solution was injected through the side of each rubber 
mold. The GMHA was permitted to dissolve overnight. The hydrogels were 
photocrosslinked by exposure to UV light for 0.5 – 20 minutes. The hydrogels were then 
removed from the molds and transferred to a large volume of either ddI water or saline 
solution for swelling. 
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 4.4.5 Synthesis of dual-crosslinked hydrogels. These hydrogels were prepared 
by the method depicted in Figure 4.2c. For each hydrogel 10 mg of GMHA was 
dispensed into a silicone rubber mold secured between two glass microscope slides. 
Crosslinking solutions consisted of aqueous solutions with an appropriate volume of 
BDDE and 0.05% w/v I2959. 100 µL of crosslinking solution was injected through the 
side of each mold. The GMHA was permitted to dissolve in the crosslinking solution 
overnight. The hydrogels were photocrosslinked by 5 minutes exposure to UV light. To 
initiate chemical crosslinking 2 µL of 10 M NaOH was added to each hydrogel to yield a 
final concentration of 0.2 M NaOH. The hydrogels were transferred to an oven and 
incubated for eight hours at 40°C. After crosslinking the hydrogels were moved to a large 
volume of ddI water for swelling. Patterned dual-crosslinked hydrogels were synthesized 
as described above with a photomask used during the UV exposure step. 
 4.4.6 Rheological measurements. The rheological properties of the HA 
hydrogels were quantified in terms of the storage modulus (G′) and the loss modulus 
(G′′). G′ gives the elastic component of the material whereas the viscous component is 
given by G′′ and both of these parameters represent the relative stiffness. Hydrogel 
samples were swollen in saline overnight and all measurements were performed in 
triplicate at room temperature. Dynamic viscoelastic measurements were performed with 
an MRC 300 modular compact rheometer (Paar Physica, Ashland, VA) using parallel 
plate geometry with a plate diameter of 25 mm and gap size of 1 mm. The moduli were 
measured at the deformation value of 0.1-10 mrad and a frequency sweep of 0.05-10 
Hz.[17] 
 4.4.7 Hydrogel swelling ratio measurements.  After synthesis, hydrogels were 
swelled to equilibrium in either water or saline consisting of 0.9% NaCl. The hydrogels 
were weighed after swelling. The swelling ratio was calculated according to Equation 1, 
where SR is the swelling ratio, WS [mg] is the swollen weight of the hydrogel, and WD 
[mg] is the dry weight of the hydrogel. The dry weight of the hydrogels was assumed as 
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 4.4.8 Degradation of hydrogels. Hydrogels were swollen to equilibrium in saline 
and then transferred to saline containing 500 U/mL of hyaluronidase. These hydrogels 
were incubated at 37°C. At selected time points the hydrogels were removed from 
solution, weighed, and returned to solution. The percentage of degradation was calculated 
by Equation 2, where W0 [mg] is the initial wet weight of the hydrogel and Wt [mg] is the 
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 4.4.9 Patterned dual-crosslinked hydrogels. The spatial patterning of 
photocrosslinking in the dual-crosslinked hydrogels was visualized by confocal 
fluorescence (Figure 4.11b) and epifluorescence (Figure 4.11c) microscopy. Fluorescent 
hydrogels were prepared by the method depicted in Figure 4.2c with fluorescein-acrylate 
mixed into the crosslinking solution and injected into the mold. The hydrogels were then 
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exposed to a photomasked UV source. Micro-patterns were created with a 
stereolithographic laser system.[21] The hydrogels were chemically crosslinked by adding 
sodium hydroxide and incubating eight hours at 40°C. The hydrogels were swollen in 
saline for 24 hours and uncrosslinked fluorescein-acrylate was removed by washing. 
 4.4.10 Statistical analysis. All data are presented as mean ± standard deviation.  
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Figure 4.1 Chemical structures of hyaluronic acid (HA), glycidyl methacrylate, and 
butanediol diglycidyl ether (BDDE). Glycidyl methacrylate was used to functionalize HA 
with methacrylate functional groups that could undergo photocrosslinking. BDDE was 















Figure 4.2 Procedure for synthesizing (a) chemically crosslinked hydrogels; (b) 















Figure 4.3 Images of chemically crosslinked super-swelling hydrogels of hyaluronic 
acid. These images demonstrate the ability of the hydrogels to maintain shape during 
swelling. Scale bars = 1 cm. (a) Disc-shaped hydrogels before swelling (left), after 
swelling in saline (middle), and  after swelling in water (right). (b) Hand-shaped button 
that was used to cast the PDMS mold (left), hydrogel after swelling in saline (middle), 













Figure 4.4 Equilibrium swelling ratios of chemically crosslinked hyaluronic acid 
hydrogels swollen in water. The hydrogels exhibit super-swelling. Dark bars correspond 
to 10% w/v HA hydrogels and light bars correspond to 20% w/v HA hydrogels. 
Increasing concentrations of chemical crosslinker (i.e., butanediol diglycidyl ether, 
BDDE) and HA decreased the swelling ratio. Note that the y-axis is plotted on log scale. 






Figure 4.5 Time-dependant profile of swelling in saline. Equilibrium swelling was 
attained within 48 hours for 10% hydrogels and 10 hours for 20% hydrogels. (a) 10% w/v 
HA hydrogels chemically crosslinked with (◊) 150 µL BDDE/g HA; (■) 250 µL/g; (▲) 
350 µL/g; (x) 500 µL/g;  (b) 20% w/v HA hydrogels chemically crosslinked with (◊) 125 
µL/g; (■) 250 µL/g; (▲) 350 µL/g; (x) 500 µL/g. Data points are the mean ± standard 











Figure 4.6 Effects of HA and BDDE concentration on the storage modulus of chemically 
crosslinked hydrogels. The rigidity of the hydrogels was dependent on polymer and 
crosslinker concentration. Storage modulus (G′) is plotted as a function of frequency. (♦) 
10% w/v HA hydrogel crosslinked with 150 µL BDDE/g HA; (■) 10% HA, 250 µL/g; (•) 
10% HA, 350 µL/g; (▲) 10% HA, 500 µL/g; (◊) 20% HA, 125 µL/g; (□) 20% HA, 250 
µL/g; (○) 20% HA, 350 µL/g; (∆) 20% HA, 500 µL/g. Data points are the mean ± 











Figure 4.7. Degradation profiles of chemically crosslinked hydrogels treated with 500 
U/mL hyaluronidase at 37°C in PBS. The degradation rate decreases with an increase in 
BDDE concentration. (♦) 10% w/v HA hydrogel crosslinked with 150 µL BDDE/g HA; 
(■) 10% HA, 250 µL/g; (▲) 10% HA, 350 µL/g; (x) 10% HA, 500 µL/g; (◊) 20% HA, 
125 µL/g; (□) 20% HA, 250 µL/g; (∆) 20% HA, 350 µL/g. Data points are the mean ± 








Figure 4.8 Optimization of photocrosslinking conditions. (a) Swelling ratio as a function 
of HA concentration. 5 minutes of UV exposure and 1% photoinitiator were held constant 
for these hydrogels. (b) Swelling ratio as a function of duration of UV exposure. An HA 
concentration of 10% w/v and 1% photoinitiator were held constant for these hydrogels. 
(c) Swelling ratio as a function of photoinitiator concentration. An HA concentration of 
10% w/v and 5 minutes of UV exposure were held constant for these hydrogels. Data 














Figure 4.9 Degradation profiles of photocrosslinked hydrogels of 10% w/v HA. The 
crosslinking conditions that exhibited the fastest rate of degradation yielded the greatest 
swelling ratios. The crosslinking conditions with the slowest rate of degradation yielded 
the least swelling ratios. (♦)  1% photoinitiator (PI), 0.5 min UV, swelling ratio (SR) = 
28; (□) 0.05% PI, 5 min UV, SR = 19; (■) 1% PI, 5 min UV, SR = 18; (∆) 0.5% PI, 10 
min UV, SR = 18; (x) 1% PI, 20 min UV, SR = 16. Data points are the mean ± standard 














Figure 4.10 Effect of dual crosslinking on viscoelasticity of HA hydrogels. Storage (G′) 
and loss modulus (G′′) as a function of frequency: (□) G′ (■) G′′ of dual crosslinked 
hydrogel;  (∆) G′ (▲) G′′ of chemically crosslinked hydrogel; (◊) G′ (♦) G′′ of 
photocrosslinked hydrogel. Hydrogels with both photocrosslinks and chemical crosslinks 
had higher storage moduli throughout the frequency range than either type of crosslinking 
alone. The hydrogels were swollen in saline overnight and then measurements were taken 







Figure 4.11 Patterned anisotropic dual-crosslinked hydrogels. (a) An anisotropically 
swelling hydrogel. Half was photocrosslinked by exposure to UV. The UV exposed (i.e., 
dual-crosslinked) region exhibited low swelling and the non-exposed (i.e., chemically-
crosslinked) region exhibited high swelling. (b) This is a fluorescent image of the 
hydrogel in (a) depicting the interface between the two crosslinking regions. The 
photocrosslinked region incorporated fluorescein-acrylate during photopolymerization. 
(c) This hydrogel demonstrates micro-patterning of dual-crosslinked and chemically-
crosslinked regions. The photomask used to pattern the photocrosslinks is shown in the 
bottom left corner. The fluorescent regions of the hydrogel correspond to dual-
crosslinked regions that incorporated fluorescein-acrylate. (d) This dual-crosslinked 
hydrogel depicts micro-patterning with a hexagonal lattice photomask. The regions 
coinciding with the mask have a high crosslink density and low swelling. The regions 
coinciding with the interstices have a low crosslink density and high swelling. The result 
is a hydrogel surface with regular repeating bumps arising from anisotropic swelling.  
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Chapter 5: Dendritic Macroporous Hydrogels of Hyaluronic Acid  
Templated by In Situ Crystallization 
 
Abstract 
We have developed a novel crystal-templating technique to fabricate hydrogels with 
dendritic porous networks. Crystal-templating works by growing a crystal template 
within a solution of uncrosslinked polymer, crosslinking the polymer around the 
template, and removing the crystals by washing with water. The result is a macroporous 
hydrogel with a network of pores matching the intricate architecture of the crystal 
template at the micron and sub-micron levels. This technique addresses the challenge of 
fabricating polymeric materials with dendritic porosity which is not possible by current 
methods. Additional advantages of crystal-templating are that it is compatible with 
natural materials, is fast, can be scaled up, and does not require any expensive equipment 
or reagents. We have used crystalline urea templates to pattern photocrosslinked 
hyaluronic acid and calcium-crosslinked alginate hydrogels for use as implantable tissue 
engineered constructs. Control over the pore morphology is important because it 
influences cellular infiltration, scaffold remodeling, nutrient diffusion, vascular 
ingrowth, and functional integration with native tissues.  
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5.1 Introduction 
 The goal of tissue engineering is to create materials that can replace or repair 
injured tissue. To that end it is desirable to have tissue engineered constructs that mimic 
the microarchitecture of native tissues. Important structural features of many tissues are 
highly branched networks of vessels and ducts (Figure 5.1). Examples are the 
bronchioles, the microvasculature, lymphatic vessels, the ductal networks of salivary 
gland, mammary gland, and kidney, and the dendritic trees produced by neurons.[1-4] 
Such networks exhibit branching, multiple length scales, a directional orientation, and 
three-dimensionality. A tissue may contain multiple entwined networks; for example, 
bronchioles,  arterial vessels, and venous vessels within the lungs. Although many 
techniques are available for creating porosity within tissue engineered constructs they 
fall short of faithfully reproducing the complexity of native tissues (Figure 5.2).[5] 
 Current techniques available for creating porosity are gas-foaming, 
lyophilization, thermally-induced phase separation and porogen leaching of salts and un-
crosslinked polymer microspheres (Table I).[6-8] The advantages of these methods are 
that they are easy to implement and scale-up. The disadvantage is that they produce 
random pore morphology and compatibility with natural materials is limited. Soft replica 
molding can transfer branched patterns from etched silicon to polymers such as 
poly(lactide-co-glycolide); however, this is an inherently two-dimensional technique and 
stacked layering methods are a poor approximation of three-dimensional porosity.[9,10] 
Rapid prototyping techniques permit precise control over pore morphology through the 
use of computer-aided design systems.[11-13] Rapid prototyping is suitable for creation of 
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square and hexagonal lattices but not the complex three-dimensional dendritic patterns 
observed in native tissues. Although rapid prototyping techniques are compatible with 
synthetic polymers they are not as suitable for natural materials which are water soluble 
and viscous. A further limitation is that the resolution of such techniques is larger than 
the length scale of individual cells and neuronal processes. Scaffolds depicted in the 
literature typically have features hundreds of microns in length which are too large to 
precisely guide cellular infiltration. Fabrication of three-dimensional multilayer 
constructs can be impractical because each scaffold must be built layer by layer with 
costly equipment.  
 Hydrogel scaffolds are uniquely suited for tissue engineering applications because 
they more closely resemble natural tissues with respect to mechanical properties, 
porosity, and water content than do other materials.[14] In particular, polysaccharides, 
such as hyaluronic acid (HA) and sodium alginate (SA) are attractive materials because 
they are composed of the same chemical building blocks as native extracellular matrix 
components. They also exhibit excellent biocompatibility and non-immunogenicity. HA 
has found use as a dermal filler, adhesion barrier, intra-articular viscosupplement, vitreal 
substitute, drug delivery matrix and tissue engineering scaffold for cartilage, skin, 
adipose, and vocal cord.[15-21] Alginate has been used extensively for cell encapsulation, 
drug delivery, and tissue engineering of adipose and cartilage.[22-24] 
 Few of the techniques developed for synthetic polymers are applicable to these 
natural biomaterials. In comparison to synthetics, these polysaccharides are considerably 
more difficult to work with because they are high molecular weight, polydisperse, 
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insoluble in organic solvents, pH and temperature sensitive, and produce viscous 
solutions even at dilute concentrations. Thus, new techniques that are compatible with 
the unique properties of these biopolymers need to be developed. To address this 
challenge we have invented a crystal-templating technique that uses in situ 
crystallization to carve out pores within biopolymer hydrogels. Salts and small organic 
molecules can precipitate as crystalline branching networks under certain conditions. 
The similarity between such networks and the dendritic patterns of microvasculature and 
neuronal dendritic trees prompted us to use in situ crystallization to template biopolymer 
hydrogels with macroporous networks.   
 HA and SA are both linear, unbranched, anionic, high molecular weight 
polysaccharides (their chemical structures are depicted in Figure 5.3), however they are 
distinguished by their mode of crosslinking. HA can be crosslinked by derivatization with 
methacrylate side chains and exposure to UV light and photoinitiator.[25] Alginate can be 
crosslinked by addition of divalent cations which crosslink adjacent guluronic acid 
blocks.[24] We have confirmed that both modes of crosslinking are compatible with the 
crystal-templating technique. We chose urea as the crystallite because it has high water 
solubility and a propensity for extensive hydrogen bonding to permit interaction with 
biopolymer chains in solution. 
 
5.2 Results  
 5.2.1 Characterization of crystal growth and hydrogel morphology. Our 
technique consists of five steps: solution casting, solvent evaporation, crystal growth, 
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crosslinking, and rinsing. These steps are depicted in Figure 5.3. Small droplets (2 µL) of 
biopolymer and urea were cast onto microscope slides. The droplets were evaporated at 
50% relative humidity to produce thin hydrated films on microscope slides. Solvent 
evaporation is required to achieve the super-saturation conditions necessary for 
crystallization. Evaporation also greatly increases the biopolymer concentration and 
solution viscosity. The combination of high viscosity and hydrogen bonding supresses 
spontaneous urea crystallization and facilitates super-saturation which is the driving force 
for crystallization. Urea seed crystals were deposited on the tips of a fine pair of tweezers 
and applied to the centers of each HA/urea and SA/urea film. Crystal growth began 
immediately and produced long dendritic branches that radiated from the center to the 
edge of the film. Within seconds the entire volume of the hydrogel film was filled with 
urea crystals.  
 After crystallization was completed the films were crosslinked by either UV 
exposure (HA hydrogels) or calcium (SA hydrogels). Both methods of crosslinking are 
rapid and accurately preserved the configuration of the crystal template. After 
crosslinking the crystals were easily removed with water. The end products were 
hydrogels with dendritic macroporous networks. Crystal-templated HA hydrogels are 
depicted in Figure 5.4. These thin films were easily observable by phase contrast and 
polarized light microscopy. Droplets containing biopolymer and urea crystals (i.e., 
biopolymer-urea “composites”) were highly birefringent when observed through crossed 
polarizers. These composite films exhibited a characteristic maltese cross pattern 
indicative of radial alignment. The colors of the composites in polarized light appeared to 
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correspond to film thickness; the films were thickest at the center and thinnest at the 
edges. After crosslinking and rinsing, the hydrogels lost most of their birefringence and 
exhibited only a faint white color when viewed through crossed polarizers. The hydrogel 
morphology consisted of aligned “fibrils” that were the inverse shape of the crystal 
template.  
 We captured images of urea crystal growth using video microscopy. The sequence 
of panels in Figure 5.5 depict high magnification images of a growing urea crystal front. 
The crystals were thin, tightly packed needles that sprouted a high density of branches. 
As the urea branches approached neighboring branches the local concentration of urea 
became depleted and branch growth was terminated; therefore, the longest continuous 
branches were those that grew in the most radial direction away from the point of 
nucleation. Direct observation of crystal growth confirmed that the crystals grew 
continuously; therefore, we conclude that the porous network within the crystal-
templated hydrogels is also continuous.  
 The micro-topography of a rinsed urea-templated HA hydrogel was observed by 
contact mode atomic force microscopy in air (Figure 5.6a). The surface of the hydrogel 
consisted of alternating parallel valleys and ridges that were carved out during crystal 
growth. During crystallization, the crystal front expels the biopolymer as an impurity. 
Thus, the biopolymer was compressed into the interstices between urea crystals and 
formed the radially aligned thin ridges. A profile of the hydrogel perpendicular to the 
length of the ridges is shown in Figure 5.6b. The dimensions of these ridges, less than 1 
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µm in height and spaced between 1 and 2 µm apart, demonstrate the fidelity of the 
crystal-templating technique on the micron and sub-micron length scales.  
 The hydrogels were rendered fluorescent by dissolving a small amount of TRITC-
conjugated dextran into the GMHA solution prior to solvent casting. Like GMHA, the 
fluorescent dextran was phase separated from the urea crystal template permitting the 
hydogel phase to be imaged by confocal fluorescent microscopy. The non-fluorescent 
crystalline phase was easily distinguishable from the fluorescent hydrogel phase. Branch 
points within the porous network were observed throughout the hydrogel volume. A 
volume reconstruction of a series of confocal z-slices illustrates that the urea crystals 
grow throughout the entire volume of the hydrogel (Figure 5.7a). Scans of individual z-
slices of samples with urea crystals and without urea crystals (imaged both in water and 
dry) demonstrate that the hydrogel preserves the macroporous network after template 
removal (Figures 5.7b-d). 
 Branches were not observed when urea crystals were grown in the absence of 
biopolymer which indicates the importance of viscosity to induction of dendritic growth. 
Such an effect has been observed by others who have examined crystal growth in the 
presence of polymers.[26,27] We found that both crystal growth rate and crystal 
morphology were dependent on the degree of super-saturation (i.e., the ratio of urea and 
HA concentrations). Super-saturation was adjusted by fixing the initial HA solution 
concentration at 10 mg/mL and varying the urea concentration from 2.5 to 180 mg/mL. 
Crystal growth could not be nucleated for a ratio of 0.25. For increasing ratios, the 
growth rate increased until reaching a rate of 1000 µm/sec for a ratio of 6 (Figure 5.8). 
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For ratios of 8 and greater, a viscous liquid was expelled from the crystals shortly after 
crystallization. This liquid was clearly visible under polarized light as dark liquid on the 
surface of the birefringent urea crystals. The liquid was likely rich in HA and 
photoinitiator which are impurities with respect to urea crystals. At higher ratios the urea 
crystals became increasingly more tightly packed, more needle-like and less branched. 
Bulk polyhedral urea crystals were observed on the surface of the needle crystals when 
the ratio was 18. We concluded that ratios of 6 and under were most effective at 
templating the biopolymer because higher concentrations produced urea crystals that 
were increasingly less branched and too tightly packed for effective templating. 
  Urea crystal growth can be nucleated by either spontaneous nucleation or by seed 
crystal application. Spontaneous nucleation occurs when the concentration of urea 
exceeds a critical super-saturation. Typically, spontaneous nucleation occurred on the 
edges of the hydrogels. Hydrogels never had more than one spontaneous nucleation event 
because crystal growth was very rapid.  We found that applying a seed crystal to initiate 
urea crystal growth was a simple method for controlling the macro-morphology of the 
crystal template. To do this we used humid conditions that suppressed spontaneous 
nucleation. At equilibrium under 50% relative humidity the moist hydrogel films have a 
concentration of urea great enough to support crystal growth from a seed crystal but too 
low for spontaneous nucleation. Un-nucleated hydrogel films could be maintained for up 
to several days until the introduction of a seed crystal. This permitted us to select both the 
time and location of the nucleation. Individual seed crystals produced radial crystal 
growth. Films produced by the application of one seed in the center of the film are 
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depicted in Figure 5.9a. Simultaneous application of three seeds produced the three 
domain template in Figure 5.9b. A line of seeds produced parallel alignment throughout 
the hydrogel film (Figure 5.9c). Thus, seed nucleation is a simple method for engineering 
template morphology.   
 5.2.2 Degradation of templated hydrogel films. The droplets deposited on 
microscope slides formed thin films a few microns thick as estimated by electron 
microscopy. Crosslinked films could be released from the surfaces of the microscope 
slides by agitation and transferred to solution for storage if desired. These films remained 
intact and did not fall apart. Some hydrogel film samples were transferred to solutions 
containing the degradative enzyme, hyaluronidase. The mesh size of GMHA hydrogels is 
too small to permit ingress of the hyaluronidase enzyme into the bulk of the hydrogel; 
thus degradation was surface-mediated and exhibited three distinct phases. In the first 
phase, surface degradation of the dense fibrillar hydrogel resulted in partial dissociation 
of the fibers and a frayed morphology at the periphery of the hydrogel (Figure 5.10a). 
During this phase, the mechanical integrity of the bulk hydrogel became increasingly 
compromised as the surface-mediated degradation continued to dissociate hydrogel 
fibers. The second phase was characterized by catastrophic failure of the bulk hydrogel 
precipitated by mild mechanical stress from routine handling (Figure 5.10b). The third 
phase was the degradation of the remaining dissociated fibers. We infer that if urea-
templated hydrogels were implanted in vivo they would also exhibit the three phases of 
slow surface degradation, bulk catastrophic mechanical failure, and slow degradation of 
dissociated fibers. 
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 5.2.3 Scale-up of urea-templated hydrogels. Scale-up of the urea-templating 
procedure was accomplished for both HA and SA using a procedure similar to that used 
for the droplets. The scaled-up films were prepared by casting 2.6 mL of solution into 12-
well plates with diameters of 2.2 cm. Three to four days were required to evaporate the 
solvent. Crystal growth could be nucleated both spontaneously and by seed crystal. 
Crystal-templated films were opaque white and had a fibrillar morphology observable 
even by eye (Figure 5.11a). In contrast, non-templated films of HA were transparent and 
featureless. Non-templated SA films were a light milky white and had a fine granular 
morphology when viewed under phase contrast microscopy. All templated and non-
templated HA and SA films were durable, pliable and easy to handle in both dry and 
swollen conditions. 
 Scaled-up templated films were too thick for their features to be observed by 
transmittance light microscopy; therefore, the morphology of these films was investigated 
by scanning electron microscopy (SEM). Dehydration of swollen hydrogel specimens can 
easily create artifacts in the hydrogel structure particularly on the surface. To minimize 
such artifacts the SEM specimens were extensively soaked and rinsed with methanol 
rather than water to remove urea. Urea is highly soluble in methanol (~160 mg/mL) and 
the templated hydrogel swelled minimally. The urea crystals had been so tightly packed 
that the templated HA hydrogel had a fibrillar appearance. The hydrogel has a fibrillar 
rather than dendritic morphology because it is composed of a single continuous bulk that 
was molded among the interstices of the dendritic urea crystals. When observed from the 
top-down, a repeating “arrowhead” fibrillar morphology of the film was clearly revealed 
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(Figure 5.11b). A curled portion of the film viewed at an angle revealed the interior 
crevices among the fibers (Figure 5.11c). Cross-sections of the film perpendicular and 
parallel to the fiber orientation are depicted in Figures 5.11d and 5.11e, respectively. 
These cross-sections demonstrate that the pore and fiber morphology were present 
throughout the thickness of the film and not confined to the surfaces; thus, confirming 
that the templates are three-dimensional. 
 Thermal gravimetric analysis was performed to assess whether water-rinsing was 
sufficient to remove urea from scaled-up, thick hydrogel films. Four samples were 
analyzed: (i) urea; (ii) uncrosslinked, non-templated GMHA hydrogel film; (iii) 
uncrosslinked, urea-templated GMHA hydrogel film containing 80% w/w urea before 
rinsing; and (iv) crosslinked, urea-templated GMHA hydrogel film after rinsing. 
Similarity among degradation profiles was assessed by comparing the temperatures 
corresponding to onset of weight loss. Before rinsing, the degradation profile of the urea-
templated hydrogel film was similar to urea; both exhibited broad weight loss at 150°C 
(Figure 5.12). After rinsing, the degradation profile of the urea-templated hydrogel film 
was similar to non-templated GMHA; both exhibited sharp weight loss at 220°C and an 
absence of the 150°C weight loss characteristic of urea. These data demonstrate that 
water-rinsing was sufficient to wash out all urea; thus, scaled-up hydrogel films consist 
primarily of hyaluronic acid without detectable urea. 
5.3 Discussion 
  Crystallization begins at a point of nucleation and then radiates outward filling 
the entire three dimensional volume. This process of growth ensures that the resulting 
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pores are interconnected and oriented. Importantly, the crystals were suspended within 
the viscous biopolymer solution permitting crystal growth in three dimensions. Scale-up 
was achieved because crystallization occured rapidly over large distances. We found that 
the crystallization of urea within HA and SA hydrogels was both reproducible and highly 
robust with respect to the concentrations of urea and biopolymer. This robustness to 
concentration permitted the hydrogels to be scaled from droplets to large films. The 
formation of the crystal templates was, however, sensitive to ambient humidity which 
affected the rate of solvent evaporation and the final water content of the evaporated, 
equilibrated hydrogel films. This sensitivity was circumvented through the use of 
controlled humidity conditions. Although crystal-templating lacks precise control over 
the final pore morphology this can be alleviated through temporal and spatial control of 
the nucleation event through the use of seed nucleation. 
 In addition to hyaluronic acid and alginate we have also confirmed that 
poly(ethylene glycol) acrylate hydrogels are patternable by urea crystallization (Figure 
5.13). Exploration of other crystallites and crystal growth conditions will yield a range of 
template morphologies. For example, we have engineered potassium phosphate templates 
that possess dendritic structures that are much larger and thicker than the urea templates 
(Figure 5.13c). We are currently exploring a variety of growth conditions with the goal of 
engineering templates closely similar in shape and dimension to neuronal dendritic trees 
and microvasculature. Crystal engineering methods can tailor the supramolecular 
assembly of crystalline materials by manipulating crystal growth conditions. Important 
parameters are the concentrations and ratios of biopolymer and urea, solution viscosity, 
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pH, and temperature. Additives such as surfactants and chiral molecules can selectively 
adhere to crystal faces and thereby control the branching, size and chirality of the 
resulting crystal structures.[28] Such techniques may refine the crystal structures and 
produce a wide selection of crystal templates.  
 Our target application for crystal-templated hydrogels are macroporous tissue 
engineering scaffolds. Urea-templated hydrogels possess micro-architecture on a length 
scale suitable for infiltration and guidance of neuronal axons and dendrites. Although the 
macropores are very small the bulk hydrogel should permit oxygen and nutrient diffusion 
to the interior of the scaffold. Presently, we are working on creating larger branched 
structures, such as in Figure 5.13c, with length scales more suited for infiltration of cell 
bodies and micro-vessels. Additionally, crystal-templated hydrogels offer a unique 
platform for the creation of composite materials. We envision that polymerization 
reactions and biomineral growth within the pores can yield novel composites in which 
one component is distributed throughout the other in oriented branched micron-sized 
pores.  
 
5.4 Materials and Methods 
 5.4.1 Materials. Sodium hyaluronate from Streptococcus equi of molecular 
weight 1.6x106 Da as indicated by the supplier, low viscosity alginic acid from brown 
algae, and bovine testicular hyaluronidase (1000 U/mg) were obtained from Sigma-
Aldrich (St. Louis, MO). Tetra-functional poly(ethylene glycol) acrylate (PEG4A, MW = 
10 kDa) was obtained from SunBio. Photoinitiator, Irgacure 2959, was obtained from 
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Ciba Specialty Chemicals (Basel, Switzerland). Photopolymerizations were initiated by a 
longwave UV lamp filtered around 365 nm and with an intensity of 22 mW/cm2 (Blak-
Ray B-100A, UVP, Upland, CA). Photocrosslinkable hyaluronic acid was prepared by 
our standard procedure of derivatization of HA with glycidyl methacrylate to yield 
GMHA (modifications to this protocol discussed in Chapter 4).[25] 
 5.4.2 Synthesis of Crystal Templated Hydrogels. Urea-templated GMHA films 
were prepared as depicted in Figure 5.3. An aqueous solution was prepared of 10 mg/mL 
GMHA with 40 mg/mL urea and 0.5 mg/mL Irgacure 2959 photoinitiator in distilled 
deionized water. Solutions also contained 0.1 mg/mL dextran-TRITC when hydrogels for 
confocal flourescent microscopy were prepared. Droplets of 2 µL were dispensed onto a 
glass microscope slide. The solvent was partially evaporated overnight at ambient 
conditions or in sealed containers with ~50% relative humidity maintained by saturated 
solutions of calcium nitrate. GMHA is very hygroscopic and retained residual moisture in 
equilibrium with the humid atmosphere. Thus, evaporation yielded viscous hydrogel 
films that were super-saturated with urea. After drying, urea seed crystals were deposited 
onto the tips of a fine pair of tweezers by scraping the tweezers against solid urea. Then 
the tweezers were carefully touched to the center of each droplet to nucleate 
crystallization. Similarly, a razor-blade scraped against urea was used to nucleate 
continuous straightlines. GMHA was crosslinked by 1 minute of exposure to UV. The 
hydrogels were rinsed in water to remove urea. 
 Templated alginate hydrogels were prepared as shown in Figure 5.3. Aqueous 
solutions of 10 mg/mL alginate with 40 mg/mL urea were dispensed onto microscope 
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slides and air-dried. After crystallization the hydrogels were crosslinked by incubating 
the droplet with 200 mg/mL calcium chloride solution for one minute. Rinsing with water 
removed excess calcium chloride and urea. 
 Templated PEG4A hydrogels (Figure 5.13c) were prepared from aqueous 
solutions of 60 mg/mL PEG4A, 40 mg/mL urea and 0.5 mg/mL Irgacure 2959. Potassium 
phosphate templated GMHA (Figure 5.13b) was prepared from a solution of 20 mg/mL 
GMHA, 10 mg/mL potassium dihydrogen phosphate and 0.5 mg/mL Irgacure 2959. 
These droplets were incubated in humid chambers equilibrated with saturated sodium 
chloride solutions (i.e., relative humidity ~75%) until crystal growth was complete. 
Alginate hydrogels templated with βCD were prepared from aqueous solutions of 30 
mg/mL alginate and 15 mg/mL βCD. Droplets were dried and βCD crystals were grown 
at ambient temperature and humidity. 
 5.4.3 Enzymatic Degradation. Degradation was carried out in a solution of PBS 
containing 500 U/mL hyaluronidase. Microscope slides with urea-templated GMHA 
films were submerged in hyaluronidase solution and incubated at 37°C for 96 hours. The 
entire volume of hyaluronidase solution was replaced after 48 hours with freshly 
prepared. 
 5.4.4 Scale-up of Crystal Templated Hydrogels. Thick crystal-templated 
hydrogels were prepared under sterile conditions to prevent contamination during solvent 
evaporation. Aqueous solutions were prepared as described above, filter sterilized (0.22 
µm PVDF, Millipore), and dispensed into sterile, non-tissue culture treated 12-well 
plates. Each well was 2.2 cm in diameter and a volume of 2.6 mL of sterile solution was 
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dispensed per well. The solvent was evaporated in a sterile horizontal flow hood in the 
dark for four days. During this time urea crystallization either nucleated spontaneously or 
was nucleated by the seed crystal technique. GMHA films were crosslinked by 1 minute 
of UV exposure, and rinsed extensively with exchanges of water over several days to 
remove urea. Alginate films were crosslinked by immersion in 200 mg/mL calcium 
chloride for twenty minutes and then rinsed extensively with water.  
 Plain GMHA films required an additional humidifying step after air-drying and 
before photocrosslinking. This step was required because the photocrosslinking reaction 
was moisture sensitive. It is likely necessary for water to be retained within the film to 
permit diffusion of photoinitiator and movement of GMHA chains during photoexposure. 
Therefore, air-dried films were placed in a sealed container at ~85% relative humidity 
which was achieved by equilibration with saturated potassium chloride solution. GMHA 
films were incubated under these conditions for four days and then photocrosslinked by 
exposure to UV for 1 minute. 
 Thermal gravimetry was performed with a Perkin Elmer TGA 7. The mass of 
each sample was between 6.4 and 7.2 mg. Samples were heated at 40°C/min from room 
temperature to 100°C and then heated at a rate of 10°C/min from 100°C to 400°C. 
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Figure 5.1 Branching morphologies are found throughout native tissues. (A) Computer 
generated model of branching bronchioles in the human lung [29]. (B) Reconstructed 
image generated from computed tomography of rat renal vasculature [30]. (C) Ductal 












Figure 5.3 Schematic of the crystal-templating technique. 1. A droplet of biopolymer-
urea solution was deposited on a glass slide and the solvent was evaporated to achieve 
supersaturation concentrations of urea. 2. Application of a seed crystal to the center of the 
film nucleated urea crystallization. 3. The biopolymer was crosslinked by either UV or 
calcium. 4. A rinse in water removed the urea crystals leaving behind a macroporous 
hydrogel templated with the pattern of the urea crystals. 
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Figure 5.4 Polarized light (a, b) and phase contrast (c-f) microscopy images of a urea 
crystal templated hyaluronic acid hydrogel. Images depict the templated hydrogel before 
crystal removal (a-d) and after crystal removal (e, f). These images demonstrate that the 
hydrogel retained the crystal template pattern. Scale bars are 1000 µm (a, c, e) and 100 

















Figure 5.5 Time lapse series of the growing urea crystal front in hyaluronic acid captured 
with brightfield video microscopy. These images show that crystal growth was 
continuous and dendritic; therefore, pores created by the crystal templating technique are 







Figure 5.6 The surface topography of a templated hyaluronic acid hydrogel after crystal 
removal obtained by atomic force microscopy. (a) The grooves between the ridges had 
been carved by urea crystal growth. The ridges correspond to the hyaluronic acid which 
had been concentrated into the interstitial spaces between urea crystal. (b) A profile 






Figure 5.7 Confocal fluorescent microscopy of TRITC-labeled urea-templated GMHA 
hydrogels. Images demonstrate that the urea crystals grew throughout the volume of the 
hydrogel and that a macro-porous network was preserved after removal of the crystal 
template. (a) Volume reconstruction of a composite urea crystal-GMHA hydrogel. (b) 
Single z-slice of a composite urea crystal-GMHA hydrogel. (c) Single z-slice of a urea 
templated GMHA hydrogel swollen in water after crystal removal. (d) Single z-slice of a 












Figure 5.8  Crystal growth rate measured by video microscopy as a function of the ratio 
of urea/HA concentration (i.e., super-saturation). The concentration of HA was fixed at 
10 mg/mL and the concentration of urea was varied from 2.5 mg/mL to 80 mg/mL. The 
urea crystal growth rate increased as the ratio of urea/HA increased (i.e., increasing the 
super-saturation of urea increased the crystal growth rate). Ratios greater than 8 produced 











Figure 5.9 The urea seed crystal technique can be used to control the morphology of 
crystals and pores within HA hydrogels. (a) One nucleation point in the center of a 
hydrogel. (b) Three separate and simultaneous nucleation points produced a hydrogel 
with three radial patterns. (c) A line of nucleation points created using the edge of a razor 
blade produced a hydrogel with linear alignment of crystals. (d) A magnified image of c. 















Figure 5.10 Enzymatic degradation of urea-templated GMHA films. Hydrogels were 
degraded at 37°C in a solution of PBS containing 500 U/mL hyaluronidase. (a) After 48 
hours of degradation the edges of the films had begun to fray. Scale bar is 50 µm. (b) 
After 96 hours of degradation the hydrogels were very fragile and were reduced to 










Figure 5.11 The process of urea-templating was scaled up from droplets to thick films. 
Scale bars are 10 µm. (a) Photograph of scaled-up freestanding hydrogels of urea-
templated (left) and plain (right) hyaluronic acid. (b-e) SEM images of crystal templated 
hyaluronic acid after crosslinking and rinsing. (b) Top down view. HA hydrogel was 
sculpted into a “fibrous” morphology. (c) This portion of the film was curled back to 
expose the crevices in the hydrogel that had been created by urea crystals. (d) Cross-
section of the hydrogel perpendicular to the pore orientation depicting that the pores are 
present throughout the thickness of the hydrogel. (e) Parallel cross-section depicting the 




























Figure 5.12  Thermal degradation of hydrogel samples obtained by thermal gravimetric 
analysis. The percent weight loss is plotted as a function of temperature. Scan rate was 
10°C/min. Four samples were analyzed: urea (□); uncrosslinked, non-templated GMHA 
hydrogel film (○); uncrosslinked, urea-templated GMHA hydrogel film containing 80% 
w/w urea before rinsing (∆); and crosslinked, urea-templated GMHA hydrogel film after 
rinsing (◊). Unrinsed, templated GMHA films had degradation profiles similar to urea; 
however, after rinsing they had degradation profiles similar to non-templated GMHA. 
These data indicate that extensive water rinsing was sufficient to remove urea from 









Figure 5.13 Polarized light (a, b, d) and phase contrast (c) microscopy images of 
hydrogel-crystal composites. (a) Urea crystal and alginate. (b) Urea crystal and 4-arm-
PEG acrylate. (c) Potassium phosphate crystal and hyaluronic acid. (d) βCD crystal and 





Chapter 6: Patterned Hydrogel Meshes  
for Living Cell Microarrays 
 
Abstract 
Living cell microarray technology is expected to enable a number of cell-based assays 
and diagnostic tools that would be highly synergistic with existing DNA and RNA 
microarrays. Current methods for creating living cell microarrays rely on clean room 
equipment and lithographic techniques, but this requirement hampers the adoption of 
living cell microarray technology by many research groups that lack microfabrication 
expertise. This chapter describes a novel method for obtaining cell microarrays that 
circumvents the need for clean room labs and lithography. Here we show that an array of 
hydrogel compartments on glass and TCPS can be readily obtained by patterning with an 
inexpensive, off-the-shelf, polymer mesh. These hydrogel compartments can produce 
living cell microarrays by isolating individual cells and cell clusters. We have obtained 
patterned hydrogels compartments using photocrosslinked hyaluronic acid, calcium-
crosslinked alginic acid, and pH-induced gelation of chitosan. The advantages of this 
technique are that it can cover wide areas, is compatible with both glass and TCPS, 
requires no clean room equipment, and does not require any highly specialized technical 
or chemical synthetic skills. This patterning technique answers the need for a simple, 
inexpensive method for obtaining living cell microarrays that can be easily disseminated 
to non-specialist research groups. 
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6.1 Introduction 
 The ability to precisely pattern living cells within a standardized array would 
have applications in medical diagnostics, cell-based sensors, and would be highly 
complementary with existing technology for DNA and RNA microarrays.[1-3] A DNA 
microarray consists of a substrate patterned with islands of immobilized DNA 
oligomers. These arrays are fabricated using either contact printing with robotic pins or 
non-contact printing with inkjet printers.[4] Methods for patterning cells and interfacing 
them with DNA microarrays is desired to fully exploit microarray technology. Current 
methods completely cover the DNA array with a continuous layer of cells to create a 
“cellular microarray” in which the DNA is patterned in islands but the cells are not.[2] 
Although this method of cell blanketing is easy to perform it permits the cells to migrate 
among DNA islands and sample multiple DNA sequences. A true cell microarray would 
confine the cells to particular islands of DNA sequences.  
 To create true cell microarrays DNA printing equipment can be modified to 
dispense cells. For example, a DNA microarray printing robot has been adapted to print 
libraries of yeast mutant strains onto microscope slides.[5] This method uses steel 
printing tips to transfer cell suspension to a substrate to yield 200 µm diameter spots 
spaced 410 µm apart. A similar approach which also used a DNA contact printing robot 
employed a deformable substrate that “cratered” when impacted by the printing pins.[6] 
The result was an array of Escherichia coli deposited in craters of 125 µm in diameter 
and separated by 375 µm. The large spacing between bacterial colonies resulted in a low 
spot density and it is unclear whether these printing methods are compatible with 
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mammalian cells. This method could be improved if there were a way to sequester a 
high density of cell colonies within identical microenvironments.  
 The primary hurdle to obtaining living cell microarrays is the difficulty of 
fabricating a substrate that can control cell adhesion.[7] The pre-dominant strategies use 
lithographic methods to pattern non-adhesive substrates with arrayed islands of cell-
adhesive ligands.[8] Cells that are seeded upon these substrates cluster within the islands 
to form the cellular array. The converse of this strategy is to pattern an adhesive 
substrate with a non-adhesive hydrophilic polymer such as hyaluronic acid or 
poly(ethylene glycol).[9] Cells seeded upon this type of substrate adhere to regions that 
are not covered with the polymer and thus form the cellular array. Both strategies are 
compatible with the techniques of soft lithography and photolithography; however, 
reliance on lithography hampers the spread of cell microarray technology to biological 
research groups that do not have micro-fabrication expertise and access to specialized 
clean room labs. Therefore, we have developed a simple cell patterning method that can 
be easily disseminated to other labs. 
 A cell microarray should consist of patterned cells within a grid in which each 
cell cluster can be assigned a unique set of coordinates. Each compartment of the array 
should be about 50-100 µm in length to accommodate several cells. Smaller 
compartments can be used to isolate individual cells. The distance separating 
compartments should be minimized to increase the density of compartments within the 
array but without compromising the isolation of each compartment. 
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 We recognized that the geometry of a woven polymer mesh is almost exactly the 
geometry that is required for cell microarrays. In particular, Nylon mesh screening is 
abundantly available, off-the-shelf, inexpensive, and can be produced with mesh 
openings as small as a few microns. The Nylon mesh used in this method is a plain 
weave in which the warp and weft threads pass over and under each other (Figure 6.1). 
The mesh openings ranged from 90 µm to 36 µm and the thread diameters ranged from 
33 to 39 µm according to the manufacturer (Table I). There is no need for lithographic 
methods to create a grid pattern from scratch because the Nylon mesh is already in the 
grid pattern. Thus, one only needs to transfer the grid pattern from the Nylon mesh to a 
non-cell adhesive hydrogel on the surface of a cell-adhesive substrate to obtain an array 
of hydrogel compartments. A cell microarray can then be readily obtained by seeding 
cells within the compartments. Our objectives for this work were (i) develop a method 
for creating an array of hydrogel compartments from Nylon mesh and (ii) use the  
hydrogel compartments to create living cell microarrays. 
  
6.2 Results 
 6.2.1 Synthesis of Hydrogel Meshes. The steps for obtaining cell microarrays 
from hydrogel meshes are schematically illustrated in Figure 6.2. First, a piece of Nylon 
mesh is coated with an aqueous solution of biopolymer and deposited on top of the 
substrate. The solvent is evaporated through the mesh openings. During evaporation the 
biopolymer solution recedes from the mesh openings and becomes concentrated between 
the substrate and the Nylon mesh. The process of drying can be easily followed under 
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the microscope (Figure 6.3). After the solution has evaporated the Nylon mesh is 
carefully removed and a viscous hydrogel solution in a mesh pattern is left remaining on 
the substrate. The hydrogel solution must then be crosslinked to stabilize the mesh 
against dissolution in water. Crosslinking can be accomplished by photocrosslinking of 
GMHA, ion-gelation of alginic acid, and pH-induced gelation of chitosan.  
 The size of the hydrogel compartment determines how many cells can fit within 
each element of the array and is determined by the Nylon mesh size; however, the 
hydrogel compartments are not exactly identical to the Nylon mesh openings. The width 
of each hydrogel compartment is about equal to the sum of the mesh opening and the 
thread diameter because the hydrogel walls formed during evaporation are much thinner 
than the Nylon threads (Figure 6.3b). For example, a Nylon mesh with 64 µm openings 
and 33 µm diameter threads yields hydrogel compartments with widths of 92 µm (Figure 
6.3c). The Nylon mesh can be cut to any size and can cover very large areas. To 
illustrate this we patterned a 150 mm tissue culture dish with 70 µm hydrogel 
compartments. The result was a dish containing roughly 1.8 million hydrogel 
compartments (Figure 6.4). 
 The hydrogel mesh has a surprising morphology that is the result of the 
biopolymer solution closely adhering to the Nylon threads. The over-and-under weave of 
the threads results in “boat” shaped hydrogel curvature (Figure 6.5). A rough estimate 
based on the SEM images suggests that the hydrogel walls reach up to several microns 
high. This is a formidable barrier to cell migration among neighboring compartments. 
The non-adhesivity of the biopolymer hydrogel further impedes cell migration. 
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Complementary data was obtained by imaging with confocal fluorescence microscopy of 
chitosan mesh labeled with TRITC (Figure 6.6). Fluorescent labeling was easily 
accomplished by mixing chitosan with dextran-TRITC which became entangled in the 
hydrogel. The confocal images demonstrate two things: first, the height of the hydrogel 
compartments is roughly 3-4 µm; and second, the hydrogel meshes can be easily 
functionalized by adding macromolecules that become entangled in the gelled meshes. 
 Hydrogel patterning was found to be compatible with both glass and tissue 
culture polystyrene, the two most common substrates for cell studies. The meshes are not 
covalently attached to these substrates; therefore, they risk coming loose if sheared in 
solution. Qualitatively, we found that an increasing strength of adherence to the substrate 
was exhibited by hyaluronic acid, alginic acid, and chitosan in that order. GMHA 
meshes were particularly susceptible to floating off of the surface and adhered more 
strongly to TCPS than to glass. Alginic acid only sometimes floated free and chitosan 
adhered so strongly that even harsh scraping could not pull the mesh from the substrate. 
Unlike GMHA and alginic acid, chitosan is positively charged and is cast from an acidic 
solution which may facilitate adsorption to the substrate. An important factor to 
adherence is hydrogel swelling. The more the hydrogel swells in solution the more likely 
it is to float away from the substrate. GMHA hydrogels tend to swell more than either 
alginic acid or chitosan and probably explains the different adherence of these hydrogels. 
 6.2.2 Living cell microarrays. To determine whether the hydrogel meshes are 
effective at creating cellular microarrays two types of cells were seeded onto the 
hydrogel patterned substrates. Primary human dermal fibroblasts are a large cell type 
137 
that is known for robustly adhering to many substrates. Primary rat Schwann cells, on 
the other hand, are a smaller cell type that is less adherent than fibroblasts.  
 Clusters of fibroblasts were successfully cultured in a microarray within a 
hydrogel mesh of 90 µm wide compartments (Figure 6.7). Several fibroblasts were 
adhered within each compartments and calcein staining verified cell viability. Some 
fibroblasts were observed to have been trapped within the “boat” shaped curvature of the 
hydrogel mesh. When a small 70 µm wide hydrogel mesh was used only one fibroblast 
adhered per compartment. A separate microarray of fibroblasts were stained with the 
nuclear stain, DAPI, and the actin stain, phalloidin (Figure 6.8). The DAPI stain 
indicates that between one to three cells adhered per hydrogel compartment. The 
phalloidin stain indicates that the cells spread to fill the available area within each 
compartment.  
 A microarray of a second cell type, Schwann cells, was obtained within 70 µm 
hydrogel mesh. Unlike the fibroblasts, several Schwann cells fit within each 
compartment due to their smaller size. After five days of culture the GMHA hydrogel 
mesh was removed by rocking the cell culture media gently to shear the mesh and cause 
it to break free of the substrate. The cells were then stained with calcein and imaged 
(Figure 6.9). With the hydrogel mesh removed these cells would be able to proliferate 






 Nylon meshes are coated with biopolymer solution simply by dipping; therefore, 
the amount of biopolymer solution that is transferred to the substrate is inexact. If too 
little solution is transferred then the walls of the hydrogel compartments will have gaps. 
If too much solution is transferred then the evaporated solution will become so viscous 
that a thin layer of hydrogel becomes deposited across the surface of each compartment. 
This is particularly problematic because the thin hydrogel layer will prevent cells from 
adhering to the underlying glass or TCPS. Therefore, some trial and error experience is 
required by users to judge qualitatively how much solution should be placed onto the 
substrate for drying. Future work should revise the hydrogel patterning protocol to 
eliminate the need for trial and error by unexperienced users. 
 The technique described here is similar to micro-contact stamping in which a 
solution is transferred from a stamp to a substrate; however, transfer of ink occurs 
primarily by adsorption to substrate which results in a thin nanometer scale layer of ink 
patterned on the substrate’s surface. Our method uses evaporation through the mesh 
openings to obtain a viscous solution of hydrogel between the Nylon and the substrate. 
Thus, we obtain a micron scale layer of hydrogel on the substrate that is easily observed 
even by the naked eye. This hydrogel wall is a highly effective barrier to cell migration. 
 The cell studies indicate the feasibility of using the hydrogel meshes to obtain 
cellular microarrays. There are many attractive features of this technology in addition to 
the ease, inexpensiveness, and simplicity of the technique. Other patterning techniques 
that do not have physical barriers separating the adhesive islands must separate each 
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island by a wide distance to prevent cells from bridging multiple islands. In our 
technique a hydrogel wall that is thinner than the size of a cell isolates each 
compartment; thus, the density of compartments that can be fit into a given area is very 
high. Additionally, the porous hydrogel walls provide space to entrap biomolecules that 
can be delivered to the cells within the compartments, and the hydrogel walls can 
contain sensing elements that monitor and capture cytokines secreted by the arrayed 
cells. Furthermore, hyaluronic acid and alginic acid possess carboxyls and hydroxyls and 
chitosan possesses amines that can be used to attach further chemical functionalities 
after patterning. 
 Another attractive feature of the patterning is that it can be reversible. GMHA 
hydrogel mesh can be removed by agitation of the solution and alginate mesh can be 
removed by a brief treatment with the calcium chelator, EDTA. We believe that this can 
be a useful feature to obtain patterned co-cultures as others have demonstrated with 
related lithographic based patterning methods.[10] In another respect, however, this 
feature can be regarded as a limitation because the hydrogel meshes are not covalently 
attached to the substrate. The hydrogel meshes must be handled carefully to prevent 
them from accidentally separating from the substrate which would permit cells to grow 
outside the confines of the array. Chitosan hydrogels adhere very strongly to glass and 
never separate from the substrate even under extreme agitation but chitosan microarrays 
are not reversible. 
 In conclusion, hydrogel meshes are an effective means for obtaining cellular 
microarrays that is superior to other techniques with respect to cost, equipment 
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requirements and simplicity. With this method many research groups can create cellular 
microarrays without needing to learn lithographic techniques and finding access to clean 
room labs. The cellular microarrays obtained by this method are applicable to a wide 
variety of cell-based sensors and medical diagnostics that are of general interest to the 
biomedical community.  
 
 
6.4 Materials and Methods 
 6.4.1 Materials. Sodium hyaluronate from Streptococcus equi of molecular 
weight 1.6x106 Da as indicated by the supplier and low viscosity alginic acid from brown 
algae were obtained from Sigma-Aldrich (St. Louis, MO). Photoinitiator, Irgacure 2959, 
was obtained from Ciba Specialty Chemicals (Basel, Switzerland). Nylon 6/6 screening 
mesh was obtained from Small Parts Inc. (Miramar, FL). Photopolymerizations were 
initiated by a longwave UV lamp filtered around 365 nm and with an intensity of 22 
mW/cm2 (Blak-Ray B-100A, UVP, Upland, CA). Photocrosslinkable hyaluronic acid was 
prepared by our standard procedure of derivatization of HA with glycidyl methacrylate to 
yield GMHA (modifications to this protocol discussed in Chapter 2).[11]  
 6.4.2 Synthesis of Hydrogel Meshes. 1% w/v aqueous biopolymer solutions 
were prepared. Cut sections of nylon mesh were dipped into the solutions and then 
removed and excess liquid was wicked away. The solution-coated mesh was then placed 
onto a either a glass or TCPS substrate and either air-dried or dessicated as necessary. 
The nylon was removed with tweezers and left behind a hydrogel mesh adherent to the 
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substrate. GMHA hydrogel meshes were crosslinked with 1 minute of UV exposure. 
Alginate hydrogel meshes were crosslinked by soaking in a solution of 20% w/v calcium 
chloride for 3 minutes. Chitosan was dissolved at a concentration of 1% in 1 M acetic 
acid and the meshes were gelled by soaking in 10 M sodium hydroxide for 3 minutes. 
 6.4.3 Scanning Electron Microscopy. Samples were dessicated and sputter 
coated with 15 nm of platinum/palladium. Images were brightness and contrast enhanced. 
 6.4.4 Seeding of Cell Microarrays. Normal human dermal fibroblasts were 
obtained from Lonza (Basel, Switzerland) and cultured in DMEM supplemented with 
10% fetal bovine serum. Fibroblasts were cultured in standard TCPS flasks, 37°C, 5% 
CO2, passaged with 0.025% TRED, and not used past passage 10. 
 Primary rat Schwann cells were obtained from ScienCell (San Diego, CA) and 
cultured in DMEM with 10% fetal bovine serum. Schwann cells were cultured in poly-L-
lysine coated TCPS dishes at 37°C, 5% CO2, passaged with 0.25% TRED, and not used 
past passage 10. 
 6.4.5 Fixing and staining of cell microarrays. Fibroblast microarrays were fixed 
after 12 hours of culture. Cells were treated with 4% paraformaldehyde in PBS and 4% 
sucrose for 20 minutes at 37°C. Cells were permeabilized for 5 minutes with 0.1% Triton 
X-100 for 5 minutes and blocked for 30 minutes at room temperature with 3% fetal 
bovine serum in PBS. Cells were stained for actin by treatment with Alexa-Fluor 488 
phalloidin (1:400) for 60 minutes. Cell nuclei were stained by DAPI (1:1000) for five 
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Figure 6.1 Scanning electron micrographs of Nylon polymer mesh with 90 µm and 36 
µm mesh openings. Top row images are a top-down view. Bottom row images are an 








Figure 6.2 Steps for obtaining hydrogel meshes from Nylon polymer mesh. 1. A polymer 
mesh is dipped into a solution of biopolymer and then laid flat on a cell adhesive 
substrate. 2. The water evaporates through the holes in the mesh and the biopolymer 
recedes into the space between the mesh and the substrate. 3. The polymer mesh is 
removed and a hydrogel mesh adheres to the substrate. 4. The non-adhesive hydrogel 
delineates a microarray of cell adhesive compartments. The hydrogel mesh can be 
crosslinked by a method such as ion-gelation or photocrosslinking which stabilizes the 
hydrogel against dissolution. 5. Cells are seeded onto the substrate and adhere within the 
cell adhesive compartments. The patterned cells and hydrogel together constitute the cell 







Figure 6.3 Brightfield microscopy images demonstrating the patterning of hydrogel by 
evaporation through a polymer mesh. (a) Nylon 6/6 polymer mesh with 64 µm mesh 
opening. (b) Polymer mesh with a biopolymer solution that has partially dried. The 
viscous polymer solution concentrates in the space between the polymer mesh and the 
glass substrate. (c) A GMHA hydrogel mesh after removal of the nylon polymer. Scale 















Figure 6.4 Photograph of a 150 mm polystyrene tissue culture plate patterned with a 
hydrogel mesh. This dish contains ~1.8 million identical hydrogel compartments and 
demonstrates the large areas that can be patterned by this technique. Scale bars are 1 cm 











Figure 6.5 SEM micrographs of an alginate hydrogel mesh. This mesh was patterned 
with a nylon mesh containing a 90 µm mesh opening. Each hydrogel compartment is 
about 110 µm wide. This hydrogel mesh has a distinctive “boat” shaped appearance due 
to the over-and-under weave of the nylon fibers by which the hydrogel was patterned. 




Figure 6.6 Confocal fluorescent microscopy of chitosan hydrogel compartments labeled 
with dextran-TRITC. (a,b) These single scans demonstrate that the hydrogel meshes can 
incorporate macromolecules including fluorescent labels. Scale bars are 25 µm. (c) 
Three-dimensional volume projection of a series of confocal z-slices showing the height 





Figure 6.7 Phase contrast and fluorescence images of living cell microarrays patterned 
by hydrogel meshes. The cell source is normal human dermal fibroblasts. Large meshes 
yield microarrays of cell clusters (top row). Small meshes yield microarrays of individual 
cells (bottom row). (a) Clusters of fibroblasts are adhered in each compartment. (b) 
Calcein labeled fibroblasts indicating cell viability. (c) Individual fibroblasts are adhered 
within the compartments. (d) A magnified image of a single fibroblast within the 








Figure 6.8 Microarray of human dermal fibroblasts imaged by confocal fluorescence 
microscopy. These cells were seeded within a chitosan mesh, cultured for 12 hours, fixed 
and stained with DAPI nuclear stain (blue) and phalloidin actin stain (green). (a) DAPI 
staining shows that one to three cells adhered per compartment. Scale bar is 50 µm. (b) 
Phalloidin staining shows that the fibroblasts spread to fill up the available area within 
each hydrogel compartment. (c) Overlay of DAPI and phalloidin images. (d) Volume 











Figure 6.9 Microarray of primary rat Schwann cells. The cells were cultured within 
GMHA hydrogel meshes for 5 days. The hydrogel was removed by gentle agitation of the 
dish and the cells were immediately imaged. Without the hydrogel barrier the cells are 
free to proliferate and spread as normal if given adequate time. Green cells are 






























 90 39 6,009 
 64 33 10,628 
 48 38 13,521 









Chapter 7: Conclusions 
 
 7.1 Historical perspective on HA biomaterials.  HA-based materials with four 
kinds of novel properties were described in this dissertation: drug-binding, anisotropic 
swelling, dendritic porosity, and microarray morphology. To put this dissertation’s 
research into perspective the historical development of HA-based materials for 
biomedical applications is  briefly summarized here. HA was first isolated in 1934 from 
the vitreous fluid of bovine eyeballs.[1] The vitreous fluid, primarily composed of HA and 
collagen II, is an acellular space-filler between the retina and lens that stabilizes eyeball 
and absorbs shock.[2] The vitreous fluid is susceptible to a number of pathologies such as 
shrinkage, haemorrhage, and detachment.[2] It is not surprising that E.A. Balazs, an 
opthalmologist studying the composition of the vitreous at Harvard Medical School, was 
inspired to create an HA-based material that could replace the vitreous in patients 
afflicted with these pathologies. Thus, Balazs developed and patented the first method for 
obtaining purified medical grade HA from rooster comb.[3] This source of HA became the 
basis of Healon® a 1% solution of HA in PBS used to supplement the vitreous during 
opthalmological surgeries.[4]  
 HA solutions were soon adapted to function as visco-supplements of the intra-
articular joint (i.e., Synvisc®) and as injectable dermal fillers.[5,6] To obtain the necessary 
visco-elastic properties of these HA solutions, crosslinking technologies using divinyl 
sulfone, aldehydes, and epoxides were developed.[7] The modern fields of tissue 
engineering and drug delivery, however, require materials with complex properties that 
155 
cannot be obtained from these lightly crosslinked HA solutions. Therefore, engineering 
HA-based materials with novel properties and structural features is an ongoing area of 
research. Fortunately, relatively inexpensive HA that is obtained from bacteria is widely 
available for engineers to use in designing the next generation of HA-based materials.[8,9]
 The original applications of HA to the vitreous, joint fluid, and skin were 
relatively simple because all that was required was an injectable, biocompatible, viscous 
polymer solution. Above and beyond these basic properties, this work describes methods 
for engineering HA materials with a variety of complex and useful properties. An 
important enabling technology for this research that was developed by several labs, 
including previous work in Schmidt lab, is the grafting of methacryloyl and acryloyl 
functionalities to HA to render it photocrosslinkable.[10-12] The benefits of this 
photocrosslinking technology for HA hydrogels are that it works at room temperature and 
neutral pH, the reaction is rapid, and can be easily controlled by manipulation of UV 
intensity and duration. Furthermore, UV exposure can be spatially patterned using 
photomasks and lasers. The research in this dissertation uses photocrosslinkable 
hyaluronic acid (GMHA) as the basis for novel HA-based materials that span a wide 
range of applications from tissue engineering to drug delivery and microarrays.  
 7.2 Drug-binding HA hydrogels. HA hydrogels are attractive for drug delivery 
because they are biocompatible and non-immunogenic. These properties arise because 
the hydrogels consist predominantly of water. Therefore, HA hydrogels are suited for 
delivery of water-soluble proteins but not the many classes of poorly water soluble drugs. 
In Chapter 3 we addressed this problem by designing hydrogels of HA functionalized 
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with a methacryloyl β-cyclodextrin monomer. The β-cyclodextrin monomer is able to 
bind poorly water soluble drugs and conferred this property to the HA hydrogels. Drug 
binding was verified by contrasting the hydrocortisone uptake of hydrogels with α-
cyclodextrin and β-cyclodextrin. Further evidence of drug binding was obtained by 
inhibiting the hydrogels with adamantane carboxylic acid which completely prevented 
drug binding. Therefore, we concluded that HA hydrogels functionalized with βCD do 
indeed bind hydrocortisone through inclusion complexation and that this ability permits 
the functionalized hydrogels to uptake and deliver more hydrocortisone that un-
functionalized hydrogels. This is a useful finding because it is a method for combining 
the biocompatible, hydrophilic HA hydrogel with a poorly water soluble drug. HA 
hydrogels that complex hydrophobic drugs have not been previously described. 
 7.3 Dual-crosslinked HA hydrogels. By definition hydrogels swell in mass and 
volume when placed in aqueous solution. Our goal in Chapter 4 was to design a novel 
HA hydrogel that would exhibit anisotropic swelling. Our design strategy used two 
modes of crosslinking. We synthesized a super-swelling chemically crosslinked hydrogel 
and then, before swelling, we added photopatterned crosslinks. When placed in solution 
the super-swelling regions swelled to a great extent whereas the regions that contained 
photopatterned crosslinks swelled less. The result was a hydrogel that swelled 
anisotropically that may have applications as an implantable tissue engineering scaffold 
that slowly changes shape as it swells. Hydrogels with photopatterned anisotropic 
swelling have not been previously described. 
 7.4 HA hydrogels with dendritic porosity. Many methods have been developed 
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for creating polymer scaffolds with biomimetic porosity; however, no method is able to 
engineer networks of fine branched pores which is a highly desirable feature for tissue 
engineered scaffolds. Dendritic porosity would be able to guide cellular infiltration, 
microvessel invasion, and axon pathfinding in a way that random, open porous scaffolds 
cannot. In Chapter 5, we invented a “crystal templating” strategy for obtaining dendritic 
porosity based on the insight that crystals can form large branched structures. By 
crosslinking biopolymer hydrogels around such crystals we obtained unique dendritic 
networks. This crystal templating method for obtaining branched pores has not been 
previously described. 
 7.5 HA hydrogel meshes for cell microarrays. Finally, in Chapter 6 we created 
hydrogel meshes of photocrosslinked hyaluronic acid. Due to the non-cell adhesive 
nature of the hyaluronic acid we found that the meshes could be used to pattern cells 
within microarrays. This is an extremely useful invention because it addresses the 
fundamental hurdle of inventing a simple method for obtaining cellular microarrays that 
does not require expertise in microfabrication. With this method the use of cellular 
microarrays can be more readily adopted by biological research labs. A further feature of 
these hydrogel meshes is that they can be removed to release cells from hydrogel 
confinement. This method for using Nylon polymer meshes to create microarrays without 
the need for microfabrication has not been previously described. 
 7.6 Applicability of these methods to other polymers. The work in this 
dissertation was based upon hyaluronic acid but is generalizable to other polymers. Our 
methods for demonstrating inclusion complexation by GMHA-βCD hydrogels can be 
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used to evaluate cyclodextrin functionalization of any kind of hydrogel. The dual-
crosslinking method for obtaining anisotropic swelling is readily generalizable; all that is 
required are two orthogonal modes of crosslinking in which at least one mode can be 
photopatterned. The crystal templating technique has been verified with alginic acid, 
chitosan, and poly(ethylene glycol) diacrylate as well as hyaluronic acid. The essential 
requirement for crystal templating is a rapid method of crosslinking that can preserve the 
morphology of the crystals. Furthermore, we have found that changing the crystallizable 
material from urea to βCD and potassium phosphate produces very different porous 
morphologies. Lastly, microarrays of hydrogel compartments can be obtained from 
hyaluronic acid, alginic acid, and chitosan each of which have their own combination of 
advantages and limitations. 
 7.7 Recommendations and Future Work. The two aspects of this dissertation 
with the most potential for future development are the crystal templating method for 
obtaining dendritic porosity and the hydrogel mesh method for obtaining cellular 
microarrays. Only by supporting cellular infiltration will the crystal templated hydrogels 
be applicable as tissue engineered scaffolds. Future work will need to functionalize them 
with cell adhesive proteins that can permit cell adhesion and invasion. Future avenues of 
research should investigate methods for creating novel composite materials using the 
templated hydrogels. For example, polymerization reactions and biomineral growth 
within the pores would yield novel composites in which a biomineral or synthetic 
polymer phase is closely entwined with the hydrogel phase. 
 A number of applications for the hydrogel mesh microarrays are readily 
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conceivable. Many assays are commercially available that detect cell viability, 
proliferation, protein synthesis, cytotoxicity, and other aspects of cellular function. These 
assays should be adapted so that they can be applied to the local microenvironments of 
each hydrogel compartment and thereby permit individual clusters of cells to be 
monitored. This is achievable by entrapping the assay reagents within the hydrogel mesh 
and/or covalently attaching them to the hydrogel’s surface.  
 In conclusion, the novel methods and materials in this dissertation are a 
significant contribution to the engineering of HA-based materials. These novel HA 
hydrogel possess unique properties that have not been previously reported. Crystal 
templating and hydrogel meshes are particularly applicable to the fields of tissue 
engineering and microarrays and address fundamental hurdles in these fields. Future 
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Appendix: Experimental Protocols 
 
A.1 Synthesis of methacryloyl hyaluronic acid 
 
Purpose: Modify hyaluronic acid with glycidyl methacrylate to yield photocrosslinkable product. 
 
Materials 
Hyaluronic acid (HA)   Aldrich 53747 
Glycidyl methacrylate (GM)  Aldrich 151238 
Triethylamine (TEA)   Aldrich 471283 
Acetone     Sigma A18 
Deuterated water    Cambridge Isotope Laboratories DLM-4-25 
Irgacure 2959    Ciba Specialty Chemicals 
UV lamp (365 nm)   Blak-Ray Model B-100A 
 
Procedure 
Dissolve 0.5 g HA in 50 mL of water.  Mix overnight. 
Then add 3.6 mL triethylamine.  Mix thoroughly. 
Add 3.6 mL glycidyl methacrylate.  Mix thoroughly. 
Mix at room temperature in a sealed flask for 24 hours. 
Precipitate the GMHA in acetone (one part GMHA solution to 20 parts acetone). 
Pour acetone into a beaker.  Slowly add GMHA solution while stirring acetone with a glass rod or pipet. 
The GMHA will precipitate as a cottony white solid and collect on the glass stirrer. 
Stop precipitation and replace acetone if it becomes very cloudy. 
Transfer the precipitate to a dish and rinse with acetone. 
Dissolve the precipitate in 50 ml dI overnight. 
Reprecipitate the GMHA in acetone.   
Rinse in acetone and dissolve in 50 ml dI overnight. 
Freeze the solution and lyophilize for 48-72 hours. 
Store with dessicant at -20°C. 
 
This procedure produces GMHA with a degree of substitution of ~11% (11 out of 100 disaccharides bear a 
methacrylate group). Decreasing the amount of triethylamine and glycidyl methacrylate decreases the 
degree of substitution. Adding acetone to the reaction mixture increases the degree of substitution. The 
amount of reactants for 5% substituted GMHA are in 6-fold molar excess relative to HA disaccharides. The 
amount of reactants for 7% substituted are 10-fold molar excess. The other conditions use reactants that are 
20-fold molar excess. 
 








Glycidyl Methacrylate (mL) 
 
5 water 1.1 1.1 
7 water 1.8 1.8 
11 water 3.6 3.6 
23 30% acetone 3.6 3.6 
32 50% acetone 3.6 3.6 
 
NMR 
Purpose: verify methacrylation NMR. 
Prepare 0.5% GMHA in D2O. 
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Make a 1% solution of Irgacure 2959 in ddI water.  Sonicate for 30-40 minutes to dissolve. 
Store at room temperature in the dark for up to one month. 
Make a 0.5-2.0% GMHA solution in I2959 solution. 




2959 concentrations greater than 0.1% are cytotoxic. 
GMHA solutions of up to 1.5% can be filter sterilized through 0.2 µm syringe filters with a 0.8 µm pore 
size prefilter  (0.8/0.2 µm Pall Gelman Supor Acrodisc PF syringe filter). 
 
 HA TEA GM  
MW 402 101.2 142  
density (g/cm3)  0.728 1.07  
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A.2 Synthesis of methacryloyl cyclodextrin 
 















R  =  H   or
n = 6, α−cyclodextrin
n = 7, β−cyclodextrin
 
Materials 
β-cyclodextrin      Fluka 28707 
α-cyclodextrin      Sigma C4642 
Methacrylic anhdyride     Aldrich 27668-5 
Sodium hydroxide  
Dialysis Tubing (cellulose ester 500 MWCO)  Spectrum Labs 131057 
 
Procedure 
Dissolve 1 g cyclodextrin in 60 mL ddI water (0.85 g anhydrous βCD, 0.96 g anhydrous αCD). 
Add methacrylic anhydride in chemical fume hood (see Table). 
Adjust pH to ~8 with 10 M NaOH. Continue to monitor pH and adjust accordingly. 
Add a total molar quantity of NaOH up to 110% of moles of methacrylic anhydride until pH stabilizes (~4 
hours). 
Dialyze for 48 hours in 500 MWCO membrane. 
Freeze solution in liquid nitrogen and lyophilize at –50 C for 48 hours. 
 
 
Reactants per 1 g of cyclodextrin 
CD Equivalents MA MA (µL) NaOH (µL 10 M) DS 
β 4.7 525 388 3.1 
β 7.1 790 582 4.2 
β 10.6 1185 875 5.2 
     
α 4.2 610 450 2.6 
α 6.4 920 680 3.3 
α 9.6 1380 1018 4.8 
 
Notes 
β-cyclodextrin:    MW = 1134 Aqueous solubility = 1.85% stock is 15% water weight 




Methacrylic anhydride: MW = 154.16 Density = 1.035 g/ml 
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A.3 HPLC purification of methacryloyl-cyclodextrin 
 





200 mM Ammonium Bicarbonate 
AKTA Purifier instrument ((Amersham Pharmacia Biotech) 




1. Dissolve crude MAβCD in water.  Mix overnight. Remove solid particulates with syringe 
filtration (0.22 µm cellulose acetate filter). Crude MAβCD solutions greater than about 45 mg/mL 
will precipitate if left for 48 hours or longer. 
 
2. Conditions for HPLC 
  Column: C18 
  Gradient Elution: 98/2 to 45/55 
  Eluent A: Water  
  Eluent B: Acetonitrile  
  Flowrate: 0.8 ml/min 
  Injection Volume: 1 mL 
  Empty Loop with 1.5 mL 
  Length of Gradient: 12 CV 
  Program: CDMix1 
 
3. Start HPLC and measure absorbance at wavelengths 230, 235 or  240 nm. 
 
4. At end of run collect fractions 8-22.  Lyophilize. 
 
Note 1: Do not use TFA in buffer.  0.1% TFA causes oxidation of cyclodextrins. If column was previously 
run with TFA in buffer then first neutralize the column by washing with 200 mM ammonium bicarbonate 
(15.8 mg/ml) prior to run.  After fractionation check the pH of the eluted fractions with pH paper (pH 
should be > 6).  Adjust the pH to 7 with 200 mM ammonium bicarbonate if necessary. 
 





A.4 Phase solubility of hydrocortisone in cyclodextrin solutions 
 




Syringe Filters (0.22 µm PVDF)  Millipore   





Prepare 300 µL of cyclodextrin solutions of each concentration: 0, 1, 3, 5, 8, 10 and 15 mM in ddI water. 
Prepare the solutions in triplicate in 0.65 mL tubes. 
 
Add several mg of hydrocortisone to each tube. 
 
Sonicate tubes for 5 minutes. 
 
Incubate tubes at room temperature for 6 days while rotating end over end. 
 
At end of 6 days measure the concentration of hydrocortisone dissolved in solution spectrophotometrically. 
 
Prepare a standard curve of hydrocortisone absorbance (248 nm) of 100, 50, 40, and 25 mM in ddI water. 
 
Syringe filter the cyclodextrin solutions to remove undissolved hydrocortisone. Dilute the filtered solutions 
with ddI water 20-80 fold to get absorbance in range of standard curve. 
 
Construct a phase solubility diagram by plotting concentration of hydrocortisone (mM) against 
concentration of cyclodextrin (mM).  
 
Fit a line through the linear portion of the diagram and calculate the slope. Calculate the association 
constant by the following equation where Ka [mM-1] is the association constant, C0 [mM] is the solubility 
of hydrocortisone in water. 
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A.5 Hydrocortisone uptake by GMHA hydrogels 
 




Methacryloyl-hyaluronic acid (GMHA)  
Methacryloyl-β-cyclodextrin (MAβCD4)  
Methacryloyl-α-cyclodextrin (MAαCD6)  
Irgacure 2959      Ciba Specialty Chemicals 
Adamantane carboxylic acid  (ACA)    Fluka 01823 
Hydrocortisone (HC)     Sigma H4001 
Phosphate buffered saline (pH = 7.4, 10 mM) 
12-well tissue culture plates (24) 
1.5 mL tubes (256) 




Prepare 200 mL of PBS with 70 mg ACA. Stir 72 hours. Filter undissolved ACA. 
 
Prepare 450 mL of PBS with 200 mg of HC. Stir for 72 hours. Filter undissolved HC. Store in refrigerator 
until needed. 
 
Prepare 1% w/v Irgacure 2959 in PBS (20 mL PBS + 200 mg I2959). 
 
Prepare a stock solution of 6 mL PBS (with 1% I2959) and 90 mg MAβCD4 (15 mg/mL). 
 
Prepare a stock solution of 3 mL PBS (with 1% I2959) and 45 mg MAαCD6 (15 mg/mL). 
 
Prepare photopolymerization solutions of GMHA with MAβCD4 and MAαCD6. Weigh out GMHA into a 
2 dram vial. Add the appropriate amounts of PBS and PBS with MAβCD4 and MAαCD6. Stir overnight. 
 





Photopolymerize gels of GMHA-MAβCD4 with 3, 6, 9, 12, 15 mg/mL MAβCD4 (n=8, total gels = 40). 
Put gels in 12-well plates with 3 mL of PBS. Exchange PBS after 4 hours, 8 hours and 24 hours. At 48 
hours transfer gels to 3 ml of PBS saturated with ACA. Incubate at RT for 48 hours on orbital platform. 
Then transfer gels to 3 ml of PBS saturated with both ACA and HC. Incubate at RT for 7 days on orbital 
platform. 
 
Photopolymerize gels of GMHA-MAβCD4 with 0, 3, 6, 9, 12, 15 mg/mL MAβCD4 (n=8, total gels = 48). 
Put gels in 12-well plates with 3 mL of PBS. Exchange PBS after 4 hours, 8 hours and 24 hours. At 48 
hours transfer gels to 3 ml of PBS saturated with HC. Incubate at RT for 7 days on orbital platform. 
 
Photopolymerize gels of GMHA-MAαCD6 with 3, 6, 9, 12, 15 mg/mL MAαCD6 (n=8, total gels = 40). 
Put gels in 12-well plates with 3 mL of PBS. Exchange PBS after 4 hours, 8 hours and 24 hours.  At 48 
hours transfer gels to 3 ml of PBS saturated with HC. Incubate at RT for 7 days on orbital platform. 
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Transfer all gels to fresh 12-well plates with 3 mL of PBS. Incubate at RT on orbital platform. 
 
At 24 hours remove 0.5 mL of media from each well and transfer to a 1.5 mL tube. Replace with fresh 0.5 
mL of PBS. Repeat at 48 hours. 
 
Analyze samples with spectrophotometer. Read absorbance at 248 nm. 
 
If necessary collect another sample at 72 hours. 
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A.6 Hydrocortisone release by GMHA hydrogels 
 
Materials 
Methacryloyl hyaluronic acid (GMHA) 
Methacryloyl-β-cyclodextrin (M4βCD) 
Hydrocortisone (HC)     Sigma H4001 
Phosphate buffered saline (pH = 7.4, 10 mM) 
15 mL tubes  
1.5 mL tubes  




Prepare 120 mL of PBS with 53 mg of HC. Stir for 72 hours. Filter undissolved HC. Store in refrigerator 
until needed. 
 
Prepare 1% I2959 in PBS (10 mL PBS + 100 mg I2959). 
 
Prepare a stock solution of 2 mL PBS (with 1% I2959) and 30 mg MAβCD4 (15 mg/mL). 
 
Prepare photopolymerization solutions of GMHA with MAβCD4. Weigh out GMHA into a 2 dram vial. 
Add the appropriate amounts of PBS and PBS with MAβCD4. Stir overnight. 
 
Dilutions 
Conc (mg/mL) PI Soln (mL) Stock Soln (mL) 
0 1.000 0.000 
5 0.666 0.333 
10 0.333 0.666 




Photopolymerize gels of GMHA-MAβCD4 with 0, 5, 10, 15 mg/mL MAβCD4 (n=8, total gels = 32). Put 
gels in 12-well plates with 3 mL of PBS. Exchange PBS after 4 hours, 8 hours and 24 hours. At 48 hours 
transfer gels to 3 ml of PBS saturated with HC. Incubate at RT for 7 days on orbital platform. 
 
Transfer all gels to 15 mL centrifuge tubes with 15 mL of PBS. Place on rotating apparatus at 37 °C in 
oven upstairs. 
 
At 1, 2, 3, 4, 6, 8, 10, 12, 24, and 48 hours remove 0.5 mL of buffer from each tube and transfer to a 1.5 mL 
tube. Replace with fresh 0.5 mL of PBS. 
 
Analyze samples with analytical HPLC. 
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A.7 Synthesis of chemically crosslinked HA hydrogels 
 




0.1 mL rubber perfusion molds   Grace Bio-Labs JTR8R-2.5 
microscope slides 
syringe and 25 5/8 gauge needle 
0.2 M NaOH 
Butanediol diglycidyl ether (BDDE)  Aldrich 220892 
Hyaluronic acid     Aldrich 53747 




Push a rubber mold onto a microscope slide so that it adheres. 
Weigh out 10 mg of HA into the mold. 
Cover the mold with a second microscope slide and clip with two binder clips. 
Prepare a solution of 950 µL 0.2 M NaOH + 50 µL BDDE. 
Inject solution into each well until all air is replaced with solution. Avoid bubbles. 
Place gels in oven at 40°C for 8-24 hours. 
Remove gels from oven. 
Place gels in large excess of saline (0.9% NaCl) for 24 hours to reach equilibrium swelling. 
 
A.8 Hyaluronidase degradation of HA-BDDE hydrogels 
 
Materials 
Bovine testicular hyaluronidase (999 U/mg)   Sigma H3506 
Saline (0.9% sodium chloride) 
 
Procedure 
Swell hydrogels to equilibrium in saline after synthesis. Exchange buffer several times to rinse out sodium 
hydroxide solution.  
Prepare 500 U/mL hyaluronidase in saline. 
Weigh hydrogels for initial time point. 
Transfer each gel to 10 mL of hyaluronidase and place in incubator at 37°C. 
Remove hydrogels from solution, weigh, and return to solution at timepoints. 








nDegradatio t  
 





A.9 Preparation of photocured GMHA films 
 
Materials 
Methacryloyl hyaluronic acid (GMHA) 
Irgacure 2959      Ciba Specialty Chemicals 
UV lamp (365 nm, 22 mW/cm2) 
0.2 µm syringe filter 
non-TC treated 12-well plate 
 
Important: Maintain the sterility of the GMHA films. Contaminated films turn white and opaque and can 




Prepare a stock solution of 1% w/v Irgacure 2959 in ddI water. Sonicate 30-45 minutes to dissolve. Do not 
oversonicate. 
 
Weigh out 150 mg of GMHA into a 20 mL vial. 
 
Add 14.25 mL of ddI water and 0.75 mL stock Irgacure solution to the vial. The final concentration of 
I2959 is 0.05% w/v. The final concentration of GMHA is 1% w/v. 
 
 Mix GMHA solution overnight. 
 
Use a sterile non-TC treated 12-well plate for a mold. Area of one well is 3.8 cm2. 
 
Filter sterilize the GMHA solution with a 0.2 µm syringe filter directly into the 12 well plate. Use 2.6 mL 
per well.  
 
Let the solution evaporate (~4 days at ambient conditions) in a sterile tissue culture flow hood in the dark. 
 
After drying carefully remove the film from the mold with an exacto knife and tweezers. Use scissors to 
trim the edge of the film is necessary. 
 
Transfer the film to a small sterile petri dish. Crosslink films by exposing to UV lamp for 1 minute. 
 
Note: If ambient humidity is too low then the films will be too dry to crosslink. In this case place the films 
in a sterile air-tight container equilibrated with a saturated salt solution. Saturated KCl is equivalent to 84-






A.10 Preparation of urea-templated hydrogels 
 
Purpose: Create small droplet-sized hydrogels on microscope slide patterned with urea crystals. 
 
Materials 
Methacryloyl-hyaluronic acid (GMHA) 
Irgacure 2959       Ciba Specialty Chemicals 
Sodium alginate       Sigma A 2158 
Chitosan       Aldrich 448877 
Tetra-functional poly(ethylene glycol) acrylate (MW 10,000)  Sunbio 
Urea        EM Science UX0065 
Fish skin gelatin       Sigma G7041 
Dextran-TRITC       Sigma T1162 
Bovine serum albumin-FITC     Sigma A9771 
 
 
Procedure for preparing urea-templated hyaluronic acid hydrogels 
 
Prepare a 1% solution of GMHA in ddI water with 0.05% w/v Irgacure 2959 and 4% w/v urea. Stir 
overnight. 
 
Dispense a small droplet (10-40 µL) onto a glass microscope slide. 
 
Let droplet dry at ambient humidity and temperature. This can take up to 1-2 hours but is typically rapid. 
Protect from light and dust. The dried viscous droplet should attain a long-lasting metastable state of 
saturated urea solution. 
 
Scrape the tips of a pair of fine needle forceps against solid urea crystals. Touch the tips of the forceps to 
the dried droplet to nucleate crystallization. 
 
Photocrosslink the hydrogel with 1 minute of UV exposure. Rinse hydrogel in water to remove urea. 
 
Procedure for low ambient humidity 
 
It is recommended to perform the drying step at ambient conditions if possible for ease only. If ambient 
humidity is too low (during cold outdoor temperatures) then the urea will spontaneously nucleate.  
 
In this case dry the droplet in a sealed container with a saturated solution of sodium chloride (relative 
humidity = 75-78%) or calcium nitrate (relative humidity = 47-56%). The droplets should be incubated 
overnight. 
 
Open the container only when ready to nucleate crystallization.  
 
After crystalliation keep hydrogel-crystals in container until immediately prior to UV exposure to prevent 
hydrogels from drying out. 
 
Procedure for urea-templated hydrogels of other polymers 
 
Alginate solutions should be prepared with 1% alginate and 4% urea. After drying the droplet the 
crosslinking can be accomplished by covering the droplets with a small volume of 20% w/v calcium 
chloride for 2 minutes. 
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Chitosan solutions should be prepared at 1% w/v in 0.1 M acetic acid. The droplets can be gelled by 
covering the droplets with a small volume of 10 M sodium hydroxide for 2 minutes. 
 
Tetra-functional PEG-acrylate solutions should be prepared at 1% w/v with 0.05% Irgacure 2959. Crosslink 
the droplets with 1 minute of UV exposure. 
 
Procedure for functionalization of hydrogels 
 
The hydrogels can be fluorescently functionalized by addition of fluorescently conjugated macromolecules. 
Both BSA-FITC and dextran-TRITC can be used; however, dextran-TRITC is preferable because BSA 
exhibits foaming and aggregation. These fluorescently tagged molecules should be added to the biopolymer 
solutions at concentrations of 1-2% w/w with respect to the biopolymer concentration. 
 
Fish skin gelatin can be added to render the hydrogels cell adhesive. Use a concentration of 2% w/v in the 
biopolymer solutions. However, this protein alters the viscosity of the droplets and crystal morphology. If 
alginate is used then the droplets can be dessicated to obtain the typical urea-template morphology, 







A.11 Preparation of urea-templated photocured GMHA and alginate films 
 
Purpose: Create large free-standing thick films of hydrogel templated with urea-crystals 
 
Materials 
Methacryloyl hyaluronic acid (GMHA) 
Irgacure 2959       Ciba Specialty Chemicals 
Sodium alginate      Sigma A 2158 
UV lamp (365 nm, 22 mW/cm2) 
0.2 µm syringe filter 
non-TC treated 12-well plate 
 




Prepare a stock solution of 1% w/v Irgacure 2959 in ddI water. Sonicate 30-45 minutes to dissolve. Do not 
oversonicate. 
 
Weigh out 150 mg of GMHA and 600 mg of urea into a 20 mL vial. 
 
Add 14.25 mL of ddI water and 0.75 mL stock Irgacure solution to the vial. The final concentration of 
I2959 is 0.05% w/v. The final concentration of GMHA is 1% w/v. (Note: Alginate solutions should be 
prepared with same concentrations but without photoinitiator). 
 
 Mix GMHA solution overnight. 
 
Use a sterile non-TC treated 12-well plate for a mold. Area of one well is 3.8 cm2. 
 
Filter sterilize the GMHA solution with a 0.2 µm syringe filter directly into the 12 well plate. Use 2.6 mL 
per well.  
 
Let the solution evaporate (~4 days at ambient conditions) in a sterile tissue culture flow hood in the dark. 
 
Scrape the tips of a pair of fine needle forceps against solid urea crystals. Touch the tips of the forceps to 
the dried films to nucleate crystallization. 
 
Carefully remove the film from the mold with an exacto knife and tweezers. Use scissors to trim the edge 
of the film if necessary. 
 
Transfer the film to a small sterile petri dish. 
 
Crosslink GMHA films by exposure to UV lamp for 1 minute.  Crosslink alginate films by immersion in 15 




A.12 Preparation of hydrogel mesh microarray 
 
Purpose: Pattern a substrate with a microarray of hydrogel compartments. 
 
Materials 
Methacryloyl hyaluronic acid (GMHA) 
Irgacure 2959       Ciba Specialty Chemicals 
Sodium alginate      Sigma A2158 
Chitosan      Aldrich 448877 
UV lamp (365 nm, 22 mW/cm2)    Blak-Ray Model B-100A 
Tissue culture treated polystyrene 
Glass microscope slides or coverslips 




Prepare a solution of 1% w/v GMHA with 0.05% w/v Irgacure 2959. Stir overnight. 
 
Cut out a small piece of Nylon mesh. Coat the Nylon mesh with GMHA solution by dipping. 
 
Wick excess solution from the Nylon mesh if necessary. 
 
Place the Nylon mesh flat onto a suitable substrate (glass or TCPS). 
 
Dry in tissue culture hood. Time required is about 20-40 minutes. 
 
Remove Nylon mesh with tweezers. Hydrogel mesh should remain adhered to substrate. 
 





Alginate mesh can be prepared by using a 1% w/v solution of alginate. Crosslink by immersion in 20% 
calcium chloride for two minutes. 
 
Chitosan mesh can be prepared by using a 1% w/v solution of chitosan in 0.1 M acetic acid. Crosslink by 
immersion in 10 M sodium hydroxide for two minutes. Rinse to neutralize pH. 
 
Dextran-TRITC can be added to render the hydrogel mesh fluorescent. Add dextran-TRITC at a 





If hydrogel compartments are completely coated with hydrogel then wick off more solution before placing 
coated Nylon mesh onto substrate. 
 
Adherence of hydrogel mesh to substrate rather than Nylon is sensitive to ambient humidity. If hydrogel 
mesh is not adhering to substrate then place Nylon mesh and substrate in a dessicator for ~10-20 minutes 
prior to remove Nylon. However, complete dessication will also cause the hydrogels to stick to Nylon.  
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A.13 Preparation of living cell microarray 
 
Materials 




Normal human dermal fibroblasts     Lonza 
Primary rat Schwann cells      ScienCell 
Dulbeccos Modified Eagle’s Medium (DMEM)   Sigma D5648 
Fetal bovine serum (FBS)      Hyclone SH30071.03 
Phosphate buffered saline (PBS, pH 7.4, 10 mM) 
Trypsin-EDTA solution (TRED 0.25%)    Sigma T4049 
Pennicillin-Streptomycin antibiotic solution (PennStrep)  Sigma A5955 
Live/Dead Cell Viability/Cytotoxicity Kit    Invitrogen L3224 
 
Cell Culture 
Fibroblasts should be cultured in TCPS 75 cm2 flasks with DMEM supplemented with 10% FBS at 37°C 
and 5% CO2. Passage fibroblasts using TRED diluted 10x in PBS. 
 
Schwann cells should be plated in TCPS 10 cm plates coated with poly-L-lysine. Culture Schwann cells 
with DMEM supplemented with 10% FBS at 37°C and 5% CO2. Passage Schwann cells using TRED. 
 
Preparation of substrates with assembly of cell wells 
Use polycarbonate cell wells with 1 cm2 area for cell growth. Prepare thin (2-4 mm) spacers of PDMS from 
resin and curing agent. Cut spacers to same size as polycarbonate cell well. Sterilize polycarbonate and 
PDMS by soaking in 70% ethanol. 
 
UV sterilize hydrogel patterned substrates for 30 minutes in vertical tissue culture flow hood.  
 
Place a PDMS spacer onto substrate. Place a polycarbonate well on top of the spacer and secure pieces 
tightly with electrical tape. 
 
Place substrates with assembled wells in sterile 10 cm TCPS dishes and wrap with ParaFilm. Store 
substrates at 4°C until use. 
 
Preparation of living cell microarray 
Prepare 10 mL of DMEM with 10% FBS and 1:100 dilution of PennStrep. 
 
Passage cells, centrifuge, and resuspend in above media. Determine cell concentration by counting cells 
with hemocytometer. Dilute cells to about 50,000 per mL. Add 700 µL of cell suspension to each well. 
 
Incubate cells for 15 minutes then gently rock well to distribute poorly adhered cells across substrate. 
 
Incubate and rock for 1 hour. Then aspirate media and unadhered cells. Replenish media with fresh. 
 
If desired treat cells with calcein (2 µL stock 4 mM calcein diluted in 10 mL PBS) for 45 minutes to assess 
cell viability. 
 
Reference: Revzin, A., Tompkins, R.G., Toner, M. Surface engineering with poly(ethylene glycol) 
photolithography to create high-density cell arrays on glass. Langmuir 19, 9855-9862 (2003). 
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A.14 Fixing and staining of living cell microarray 
 
Purpose: Stain array of fibroblasts with DAPI and Phalloidin 
 
Materials 
Alexa-Fluor 488-Phalloidin     Invitrogen A12379 
4’6-diamidino-2-phenyl-indole dihydrochloride (DAPI)  Invitrogen D1306 
Paraformaldehyde      Sigma P6148 
Triton X-100       Fluka 93426 
Phosphate buffered saline (PBS, pH 7.4, 10 mM) 
Fetal bovine serum      Hyclone SH30071.03 
 
Procedure 
Prepare fixative solution of 4% paraformaldehyde and 4% sucrose in PBS. 
Prepare a stock of sterile PBS for rinsing. 
Prepare a stock of blocking solution (3% FBS in PBS). 
 
Rinse cells twice with PBS to remove serum proteins. 
 
Fix cells by incubating with fixative solutoin for 20 minutes at 37°C. 
 
Rinse cells twice with PBS. 
 
Permeabilize cells by incubation with 0.1% Triton X-100 in PBS for 5 minutes at room temperature. 
 
Rinse cells twices with PBS. 
 
Block cells with 3% FBS/PBS for 30 minutes at room temperature. 
 
Prepare a solution of Phalloidin-Alexa 488 (1:400 dilution in blocking solution). 
 
Incubate cells with Phalloidin for 60 minutes at room temperature. 
 
Rinse cells once with PBS. Then rinse cells twice with PBS for 3 minutes. 
 
Incubate cells with DAPI (1:1000 dilution in PBS) for 5 minutes at room temperature. 
 
Rinse cells once with PBS. Then rinse cells twice with PBS for 3 minutes. 
 
Check quality of fluorescent staining by epifluorescence. 
 
Carefully disassemble cell well without disturbing cells. Place a small volume of PBS on cells. Cover cells 
with a No. 1 coverslip and seal with nail polish.  
 
Image cells by confocal fluorescence microscopy (located in MBB 1.426). Capture single scans at 
2048x2048 resolution and z-series at 512x512 resolution. DAPI stains heavier than Phalloidin by this 
protocol so make sure that DAPI fluorescence does not bleed into Phalloidin images which will cause cells 
to look uniformly blue-green. After imaging, use Imaris workstation in MBB to assemble 3-dimensional 
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